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ABSTRACT 
The Modified Stereospecific Stille Reaction: Palladium-Catalyzed 
Cross-Coupling Reactions Involving Secondary and Tertiary Alkyl 
Carbastannatranes 
 
 
Advisor: Prof. Mark R. Biscoe                                                        by Chao-yuan Wang 
 
Organic chemistry is present in all domains of everyday life, from polymer 
production to medicine. In order to synthesize complex compounds, it is often necessary 
to make new carbon-carbon bonds. Transition metal catalysts, particularly those derived 
from second and third row metals such as Pt, Pd, Rh, and Ir metals, display remarkable 
efficiency for the formation of carbon-carbon and carbon-heteroatom bonds. In the first 
chapter, introduction of transition metal-catalyzed cross-coupling reactions is given. 
While the formation of C(sp2)–C(sp2) bonds has been studied extensively, C(sp3)-C(sp2) 
bond formation still presents a challenge due to competitive β-hydride elimination and 
slow transmetallation of bulky secondary and tertiary alkyl organometallic nucleophiles. 
Palladium-catalyzed cross-coupling reactions (especially Stille and Suzuki cross coupling 
reactions) can tolerate a broad scope of reactants, and even proceed with high 
stereospecificity.  The development of a general system that enables a broad scope of 
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reactants to be employed in reactions with high sterespecificity would be transformative 
in the field of organic synthesis and drug development. Herein, in the second chapter, we 
present the development of a general Pd-catalyzed process for the stereospecific cross-
coupling of secondary alkyl organotin reagents with aryl chlorides, bromides, iodides and 
triflates. The reaction proceeds with minimal isomerization of the secondary alkyl 
organometallic tin nucleophile, and tolerates a wide range of functional groups with 
absolute configuration. In the third chapter, this work has been extended to the use of 
acyl electrophiles, which undergo Pd-catalyzed cross-coupling reactions with secondary 
alkylcarbastannatranes with exceptional stereofidelity and with net retention of absolute 
configuration. Because the stereochemistry of the resulting products is entirely reagent-
controlled, this process may be viewed as a general, alternative approach to the 
preparation of products typically accessed via asymmetric enolate methodologies. 
Additionally, we report a new method for the preparation of optically active 
alkylcarbastannatranes, which should facilitate their future use in stereospecific reactions. 
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1] Introduction  
1.1] Background 
Biological systems, in most cases, recognize a pair of enantiomers as different 
substances, and the two enantiomers will elicit different responses. Thus, enantioselective 
synthesis is a key process in modern chemistry and is particularly important in the field 
of pharmaceuticals, as the different enantiomers or diastereomers of a molecule often 
have different biological activity. Hence, one enantiomer may act as an effective 
therapeutic drug whereas the other enantiomer could be inactive or toxic. The potential 
for the individual compounds of a racemate to exhibit disparate biological effects was 
first observed with Thalidomide in the 1950’s.1 It was initially prescribed as an anti-
emetic to alleviate morning sickness in pregnant women. Shortly after the drug was sold 
in West Germany, about 7,000 infants were born with phocomelia (malformation of the 
limbs). Only 40% of these children survived. Throughout the world, more than 10,000 
cases were reported of infants with phocomelia due to thalidomide; only 50% of them 
survived. Other effects included deformed eyes and hearts, deformed alimentary and 
urinary tracts, blindness and deafness. Worldwide, S-Thalidomide was shown to be 
responsible for over 20000 cases of serious birth defects in children born to women who 
took the racemic mixture during pregnancy. The negative effects of Thalidomide led to 
the development of more structured drug regulations and control over drug use and 
development. 
Thus, it is important that synthetic chemists provide highly efficient and reliable 
methods for the synthesis of desired compounds in an enantiomerically pure state, so that 
	 2	
the biological properties of each enantiomer can be investigated. Today, pharmaceutical 
industries must rigorously demonstrate the safety of racemates to obtain the FDA’s 
approval. Several methods are used to obtain enantiomerically pure materials, which 
include classical optical resolution via diastereomers, chromatographic separation of 
enantiomers, enzymic resolution, chemical kinetic resolution, and asymmetric synthesis.  
The importance and practicality of asymmetric synthesis as a tool to obtain enantio- 
merically pure or enriched compounds has been fully acknowledged to date by chemists 
in synthetic organic chemistry and medicinal chemistry. This prominence starts from the 
extensive development of asymmetric methods over the past few decades. Asymmetric 
synthesis, also called chiral synthesis or enantioselective synthesis, is a form of chemical 
synthesis. It is defined by IUPAC as a chemical reaction in which one or more new 
elements of chirality are formed in a substrate molecule and which produces the 
stereoisomeric (enantiomeric or diastereoisomeric) products in unequal amounts. In other 
words, it is the synthesis of a compound by a method that favors the formation of a 
specific enantiomer or diastereomer.  
Among the types of asymmetric reactions, the most desirable and the most 
challenging is catalytic asymmetric synthesis because one chiral catalyst molecule can 
create millions of chiral product molecules, just like what enzymes are capable of doing 
in biological systems. Plus, catalytic asymmetric synthesis often has significant economic 
advantages over stoichiometric asymmetric synthesis for industrial-scale production of 
enantiomerically pure compounds. For example, a number of catalytic asymmetric 
reactions, including the “Takasago Process” (asymmetric isomerization), the “Sumitomo 
Process” (asymmetric cyclopropanation), and the “Arco Process” (asymmetric Sharpless 
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epoxidation) have been commercialized from the 1980s.2 In 2001, the Nobel Prize in 
Chemistry was awarded to William S. Knowles, Ryoji Noyori, and K. Barry Sharpless in 
recognition of their contributions to the development of catalytic asymmetric synthesis. 
Their discoveries have had a significant impact on academic research, drug discovery, 
and material chemistry, where asymmetric catalysis is commonly employed in the 
creation of stereogenic centers during carbon-carbon bond construction.3 
 
1.2] The development of metal-catalyzed coupling reactions  
Transition-metal-catalyzed cross-coupling reactions of aryl halides with 
organoboronic acids, organostannanes, organosiloxanes, organozinc compounds, and 
Grignard reagents have found widespread popularity during recent years.4 However, the 
development of metal-catalyzed coupling reactions begins with some of the oldest 
organic chemistry - stoichiometric metal-promoted homo-couplings.
 
Historically, the first 
example is the copper-promoted homocoupling of metallic acetylides reported by Glaser 
in 1869.5 About a decade later, Baeyer reported the use of the Glaser coupling for the 
synthesis of indigo, which served as a forerunner of the modern combined transition-
metal-catalyzed Sonogashira-heteroannulation strategies for indoles and related 
heterocycles.6 Following the development of C(sp)-C(sp) homocoupling reactions, the 
copper-mediated method was extended to C(sp2)-C(sp2) bond formation. In 1901, 
Ullmann reported the dimerization of 2-bromo- and 2-chloronitrobenzene promoted by 
the use of superstoichiometric copper sources.7 Although the Ullmann dimerization was 
similar to the Glaser-type process that preceded it, the dimerization occurs between 
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carbons bearing halogens rather than between simple unfunctionalized carbon systems. 
This theme of using carbon atoms bearing halogens for coupling chemistry was 
concurrently being developed in the areas of organomagnesium (Grignard) and 
organosodium (Wurtz-Fittig) chemistry. Despite these remarkable achievements, the 
early metal-promoted reactions were not only limited to the use of stoichiometric or 
super-stoichiometric metal reagents but also limited to homo-coupling transformations 
while often resulting in the formation of various undesired side products. Hence, later 
efforts focused on reducing metal loading and making the transformations more selective. 
During the first half of the 20th century, the first systematic investigation of transition-
metal-catalyzed C(sp2)-C(sp2) coupling is found in a 1941 publication by Kharasch, and 
in subsequent studies during the 1940s, his work was extended to the cross coupling of 
vinyl bromides with aryl organomagnesium species using cobalt chloride.8 These studies 
represent the earliest reports of a cross-coupling product — the use of metals to connect 
two different coupling partners. Although the early Kharasch-type couplings were 
extremely limited in substrate scope and functional group compatibility, they 
demonstrated that transition metals could be used in catalytic quantities to form carbon-
carbon bonds. Unfortunately, the ratio of the homo-coupling to cross-coupling product 
observed was highly substrate specific, producing uncontrollably variable yields. Thus, 
during the second half of the 20th century, organic chemists sought new conditions that 
would increase the selectivity in favor of the cross-coupling product. In the 1960s, for the 
very first time, a robust solution to the selectivity problem had been found. With these 
first examples of truly selective C-C bond formation between C(sp) and C(sp) carbon 
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centers (Cadiot–Chodkiewicz)9 or C(sp) and C(sp2) carbon centers (Castro–Stephens),10 
the framework of the cross-coupling concept began to emerge.  
1.3] Cross-coupling reactions 
Organic chemistry is present in all domains of everyday life, from polymer 
production to medicine. In order to synthesize complex compounds, it is often necessary 
to make new C-C bonds, which can be difficult due to the stability of carbon compounds. 
Transition-metal-catalyzed cross-coupling reactions of organic electrophiles and 
organometallic reagents have emerged as a powerful synthetic tool, and its development 
has reached a level of sophistication that allows for a wide range of coupling partners to 
be combined efficiently. In the past decades, this paradigm for C-C bond construction has 
allowed chemists to assemble complex molecular frameworks of diversified interests. 
These interests encompass applications of natural product synthesis, medicinal chemistry, 
and industrial process development, as well as chemical biology, material chemistry, and 
nanotechnology. The emergence of cross coupling as a popular method in synthesis arises 
from both the diversity of organometallic reagents utilized in these reactions and the 
broad range of functional groups which can be incorporated into these reagents. 
  “Cross-coupling reaction” is a general term for a variety of reactions where 
nucleophilic and electrophilic partners are joined with the aid of a metal catalyst. 
Transition-metal-catalyzed carbon-carbon cross-coupling reactions typically involve the 
reaction of a main group organometallic nucleophile with an organic electrophile in the 
presence of a transition metal catalyst. Conventional transition metal-catalyzed cross-
coupling reactions generally proceed via the three fundamental steps in the reaction 
mechanism shown in Figure 1. The cycle begins with the electrophilic coupling partner, a 
	 6	
halide RX (or a pseudo-halide), undergoing oxidative addition to a low valent transition 
metal complex (LnM), forming the oxidative addition (OX) intermediate (LnMRX). The 
nucleophilic coupling partner varies and may be an alkene or an organometallic 
compound R1M’ (M’ belonging to the series B, Sn, Zn, Mg, Si, Cu). Subsequently, the 
oxidative addition complex undergoes transmetallation (TM) with the main group 
organometallic species or migratory mechanism if an alkene is used in place of the 
organometallic nucleophile forming the second intermediate (LnMRR
1) and a metal 
species (M’X). The final step is reductive elimination (RE) of the second intermediate in 
which a carbon-carbon bond is formed between the two coupling partners while 
regenerating the metal catalyst. The mechanistic details of these fundamental steps may 
vary depending upon the cross-coupling method employed.11  
 
Figure1. General cross-coupling catalyzed cycle 
 
RX
Reductive 
Elimination
Oxidative
Addition
Trans-
metallation
MLn
MLnR
X
R1M' M'X
MLnR
R1
R-R1
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Figure 2. Evolution of Cross-Coupling Reactions (Angew. Chem. Int. Ed. 2012, 51, 5062) 
The chemistry of cross-coupling reactions has evolved over three successive 
waves (Figure 2)4 : 1) the wave dedicated to identification and investigation of metal 
catalysts; 2) the wave dedicated to identification of the nucleophilic substrates 
(organometallic partners) able to react in these cross-coupling reactions; and 3) the wave 
dedicated to the development of new catalytically active species and alternative 
electrophilic partners. Wave one was dominated by copper, and was described earlier.4 
Subsequently, the complexity of the coupling reactions has increased since the 1960s, 
concomitant with the development of nickel and palladium catalysts. This enabled the 
development of new synthetic methodologies based on different main group 
organometallic nucleophiles (wave two).4 The ensuing development of new powerful 
ligands for use in palladium catalysis has facilitated the broad application of high 
yielding cross-coupling reactions (wave three). The ligands used in combination with 
palladium in transition metal-catalyzed cross-coupling reactions are in general: 
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monodentate phosphines, bidentate phosphines, and N-heterocyclic carbenes. In 
particular, phosphine-ligated systems have been shown to have a wide range of synthetic 
applications and are remarkably stable.4,11 The most frequently used monodentate 
phosphine is triphenylphosphine (PPh3). Palladium complexes with bidentate phosphine 
ligands tend to be more stable than those with monodentate ligands. A supplementary 
advantage of the bidentate ligands relates to the acceleration of the reductive elimination 
step, as they enforce the cis geometry necessary for reductive elimination to occur. The 
impressive progress in this area has been paved by the development of electron-rich, 
bulky phosphines4 and N-heterocyclic carbene ligands, which comprise many highly 
active nickel and palladium catalysts.12 Names associated with common cross-coupling 
reactions relate to the main group metal nucleophile employed (Figure 3): Heck (no main 
group organometallic nucleophile),13 Negishi (Zn),15 Sonogashira (Cu),16 Stille (Sn),17 
Hiyama (Si),18 and Kumada (Mg),19 Suzuki-Miyaura (B).14, 20 
 
Figure 3. General types of palladium-catalyzed cross-coupling reactions 
A major focus of the research in our laboratory is the development of new 
methods for carbon-carbon bond formation via metal-catalyzed cross-coupling reactions 
using alkyl nucleophiles.21 Recently, we reported general Ni-catalyzed processes for the 
cross coupling of secondary alkylzinc and tertiary alkylmagnesium nucleophiles with aryl 
R1-X   +    R2M2Y                    R-R2
R1, R2 = alkenyl, alkynyl, alkyl, aryl
M1 = Pd, Pt, Ni, Co, Fe, Cu
X = Halides, OTf, OTs
Y = Halides, alkyl, alkynyl
M1Lm
R2ZnY    Negishi
R2BY2    Suzuki-Miyaura
R2MgY   Kumada
R2SnY3  Stille
R2SiY3   Hiyama
R2CuY   Sonogashira
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electrophiles.22 These methods largely circumvent the β-hydride elimination/reinsertion 
sequences that have limited previous Pd-catalyzed systems (Figure 4). To expand the 
versatility of the cross-coupling reactions that use secondary alkyl nucleophiles, we also 
want to extend the processes to the use of isolable, configurationally stable, optically 
active organometallic nucleophiles.23 The development of such transformations is 
impeded by the inverse relationship that exists between the nucleophilicity and 
configurational stability of carbon-metal bonds in main-group organometallic 
nucleophiles (Figure 5).24 Although increased covalency tends to coincide with enhanced 
configurational stability of the carbon-metal bond, it also tends to coincide with reduced 
nucleophilicity.24 This trend, in addition to the inherent bulk of a secondary nucleophile, 
results in the prohibitively slow transmetallation of a secondary nucleophile as the 
covalency of the C-M bond increases. Additionally, rapid reductive elimination is still 
required to circumvent the competing β-hydride elimination pathway. 
The use of secondary alkyltin25 and secondary alkylboron26 nucleophiles 
containing a secondary C(sp3)-alkyl carbon center has typically required remote 
activation via the presence of a C(sp2) α-carbon, α-heteroatom, and/or a strongly 
coordinating β-carbonyl group on the nucleophile in order to accelerate transmetallation27 
and also retard the formation of isomerized products via competitive β-hydride 
elimination pathways (Figure 6).  Therefore, development of a more powerful organotin 
reagent capable of easy preparation with the trend for the specific and selective transfer 
of the desired inactivated secondary alkyl group during the organic synthesis remains 
challenging.  
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 Figure 4. Catalytic cycle and competing processes for Pd-catalyzed cross-coupling reactions of 
secondary nucleophiles and aryl electrophiles. 
 
Figure 5. Inverse relationship between configurational stability and nucleophilicity for main group 
organometallic nucleophiles.		
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Figure 6. Stereospecific cross-coupling reactions using isolable optically active organometallic 
nucleophiles.  
 
1.4] Pd-catalyzed Stille cross-coupling reactions 
The Stille reaction is one of the most useful transformations in organic synthesis. 
The emergence of organotin compounds as coupling mediators has led to a remarkable 
growth in the field of cross-coupling reactions over the past 40 years. Alongside the 
Suzuki reaction, the Stille reaction has established itself as one of the most general and 
most selective palladium-catalyzed cross-coupling reactions.28
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not react with most common functional groups, and are stable to oxidative and reductive 
reaction conditions, the use of protecting groups is generally unnecessary in conjunction 
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conveniently purified and stored. In addition to this attractive feature, the reaction also 
has the advantage that it runs under neutral conditions, making it potentially more 
tolerant of functional groups than the Suzuki reaction. This particular kind of cross 
coupling reaction was first observed by M. Kosugi29,30 in the late 1970s and was further 
developed by J. K. Stille. The first examples of the coupling of organostannanes with 
organic electrophiles were disclosed during the period 1976-1977 by the research groups 
of Eaborn and Kosugi,30 but it was the extensive synthetic and mechanistic work carried 
out by Stille and co-workers from 197831 that made this reaction a standard method in 
organic synthesis.  
Generally, Stille cross-coupling reactions involve the coupling of an organotin 
(IV) reagent and an organic halide or pseudohalide in the presence of a palladium catalyst 
to give the carbon-carbon coupled product.32 Palladium complexes such as Pd(PPh3)4, 
PdCl2(PPh3)2, Pd2(dba)3, Pd(CH3CN)2Cl2, Pd(Pfur3)2Cl2 (dba = dibenzylideneacetone, fur 
= 2-furyl) and palladium nanoparticles have been employed as Pd sources.33 Modern 
chemists are actively engaged in designing new organotin compounds (organostannanes) 
for their wide applications as reagents in synthetic reactions. 
 
1.5] Transmetallation of organostannanes 
The currently accepted mechanism of the Stille cross-coupling reaction contains 
four steps.34 These four steps are oxidative addition, transmetallation, trans-cis 
isomerization (cis-trans as well) and reductive elimination.35
 
The overall outcome of the 
transmetallation step is a concurrent cleavage of the carbon-tin bond and formation of the 
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carbon-palladium bond. During this process, the organotin moiety is scavenged by the 
halides to give a tin halide compound.
  
As described above, the substrate scope has been 
enlarged and it has been found that the organotin reagents can tolerate a considerable 
range of functionalities.36
 
These nucleophilic organotin reagents include alkynyltins, 
alkenyltins, aryltins, allyltins, benzyltins, acyltins, alkyltins, aminostannanes, as well as 
alkoxystannanes.37
 
Rate of transfer from tin is proportional to the amount of S-character 
in the C-Sn bond. Thus, alkynyltin and alkenyl/aryltin are considered to be the most 
reactive organostannanes toward transmetallation. These groups can selectively 
transferred from the tin atom to a palladium complex in the presence of alkyl-tin bonds 
due to the low propensity of alkyl groups to undergo transmetallation from tin. Therefore 
tributyltin (or trimethyltin) units are commonly employed to enable the selective transfer 
of alkynyl or aryl groups. The preference was given to tributyltin derivatives in most of 
the cases since these are comparatively less toxic (Figure 7).38 
 
There are relatively few 
examples of the successful transfer of primary alkyl groups in Stille cross-coupling 
reactions described in the literature (Figure 8).
39,40     
 
 
 
Figure 7.
 
Transmetallation rate of different substituents of Stille coupling 
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Figure 8.  Stille cross-coupling reactions involved tetraalkylstannanes. 
Although transfer of alkyl substituents from tetraalkylstannanes is precedented, it 
is only practical for primary alkyl (methyl or n-butyl) groups. Slow transmetallation and 
facile β-hydride elimination (when employing stannanes with alkyl groups bearing β-
hydrogen) constitute major obstacles to the application of secondary alkyltin reagents in 
Cl
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K. Burkhard, Adv. Synth. Catal., 2006, 2243.
51%
I
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Pd-catalyzed cross-coupling reactions.40  
 
 
Figure 9. First use of alkylcarbastannatranes in Stille couplings. 
In Stille cross-coupling reactions, it is not only difficult to transfer alkyl groups 
other than primary alkyl species, but during cross-coupling reactions only one out of four 
alkyl substituents migrates in the transmetallation step, while the other three substituents 
are wasted (Figure 8). The Vedejs group used methylcarbastannatrane in place of the 
traditional tetramethyltin reagent in a Pd-catalyzed Stille cross-coupling reaction to 
achieve selective, accelerated transfer of the methyl group (Figure 9).42 
Alkylcarbastannatranes were initially introduced by Jurkschat in 1985. According to X-
ray crystal structures obtained by Jurkschat, carbastannatranes have a longer apical Sn-C 
bond compared to normal tetraalkylstannanes (i.e., enhanced nucleophilicity).41 
From our point of view, one of the best strategies to resolve common problems 
associated with unactivated alkyl group transfer is to increase length and to enhance 
polarity of the Sn-C bond of interest. Hence, carbastannatranes turned into interesting 
coupling mediators. In principle, use of carbastannatranes also enables the selective 
transfer of the single apical alkyl group, eliminating the need to sacrifice three 
Br
MeO
Pd(PPh3)4 (3 mol%)
toluene,  75 ºC
Me
MeO < 5 %
SnMe4
SnN Me
Br
MeO
Pd(PPh3)4 (3 mol%)
toluene,  75 ºC
Me
MeO 67 %
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(potentially precious) alkyl units. Consequently, the use of carbastannatranes in Stille 
cross-coupling reactions may offer a number of advantages over the use of more 
traditional organotin reagents including milder reaction conditions, selective and 
stereospecific alkyl transfer, and lower toxicity (carbastannatranes).43  
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2] Stereospecific Pd-catalyzed Stille cross-coupling reactions of 
secondary alkylcarbastannatranes and aryl electrophiles  
	
2.1] Choice of nucleophileImportance of carbastannatranes as 
coupling mediators 
In organotin chemistry, it has been observed that the intramolecular donation of 
nitrogen to tin increases the reactivity of the trans-situated Sn-R bond,1 making some 
cyclic organotin reagents useful in synthetic routes.2 Amongst potential organotin cyclic 
systems, stannatranes possess cage like structures with transannular donor-acceptor 
interaction.3,4 In stannatranes, the tin atom is coordinated to the heteroatoms of a tripod-
like tetradentate ligand, which generates heterocyclic N-C-C-Y-Sn (Y: heteroatoms; 
Figure 1) chelate rings containing the 
apical Sn-N bond and tin in a bridge-
head position. Depending upon the 
equatorial atoms (Y), stannatranes are 
categorized into stannatranes (Y = 
oxygen), azastannatranes (Y = nitrogen) and thiastannatranes (Y = sulphur), and none of 
them have been reported as coupling mediators. Only carbastannatranes (Y = carbon) 
have been used in cross-coupling reactions.  
Compared to tetraalkylstannanes, alkylcarbastannatrane possess a longer apical 
Sn-C bond as a consequence of the intramolecular Sn-N bond according to X-ray crystal 
structures obtained by Jurkschat in 1985.1 This transannular Sn-N interaction should thus 
result in the selective labilization of the trans-disposed alkyl substituent.5,6 The coordina-
Y
SnN
Y
Y
X
Figure 1.  Stannatranes ( Y = O, N, S , and C)
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tion of the nitrogen atom in benzyl amines (1, Figure 2) as well as carbastannatrane 
derivatives (2a, Figure 2) has been demonstrated to be particularly effective in facilitating 
the selective transfer of the alkyl group in Stille cross-coupling reactions.6 Thus, we 
proposed that the carbstannatrane backbone could be broadly employed to selectively 
activate apical primary, 
secondary, and tertiary 
alkyl substituent towards 
transmetallation,8 provid-
ing the more efficient reagent by which to transfer alkyl group compared to traditional 
tetraalkylstannane reagents. 
 
2.2] Optimization  
Different phosphine ligands were screened with sec-butyl carbastannatrane (2b) 
as the nucleophile and with 4-bromoanisole as the electrophile. The initial conditions 
were set on the 0.02 mmol scale	using 5 mol % Pd(dba)2 in acetonitrile (Figure 3). Reac-
tions were conducted under an argon atmosphere and were stirred at 60 ºC. Reactions 
were monitored by gas chromatography, and the yield of desired product was calibrated 
using dodecane as the internal standard. Reactions were also screened in the presence of 
CuCl (2 equiv) and KF (2 equiv). Low conversions and a preponderance of rearrange-
ment product resulted from the use of most ligands (Figure 3). Only one ligand, Jack-
iePhos (3), a bulky electron-deficient biarylphosphine, emerged as a promising ligand for 
this transformation. This commercially available ligand was developed by the Buchwald 
NMe2
SnPh2
Me
SnN Alkyl1 2a
Figure 2.  The coordination of the nitrogen atom to tin atom.
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group to facilitate the rate-limiting transmetallation of secondary amides in Pd-catalyzed 
amidation reactions of aryl halides.9-12  
In our opinion, the efficacy of Jackiephos as a supporting ligand in the cross-
coupling reactions of secondary alkylcarbstannatranes likely results from the propensity 
of Jackiephos to facilitate transmetallation of the secondary alkyl group while still pro-
moting rapid reductive elimination. This interpretation is supported by the use of Jack-
iephos analogue L4, which lacks trifluoromethyl group on the phenyl rings.  In presence 
of 10 mol % L4, the yield and the retention/ isomerization ratio decreased significantly 
(Figure 3).		This is consistent with slower transmetallation and slower reductive elimina-
tion.
 
Figure 3. Ligand effects on the Pd-catalyzed cross-coupling reaction of 2b and 4-bromoanisole.	
  
P
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i-Pri-Pr
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85 57 10 9
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     L2                    1                         NA
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  As mentioned in chapter one, the Stille reaction has established itself as one of the 
most general and most selective palladium-catalyzed cross-coupling reactions,
 
along with 
the Suzuki cross-coupling of organoboron compounds. The Stille coupling is particularly 
popular as organostannanes are readily prepared, purified and stored. As hydroxo ligands 
play a major role in the transmetallation step of the Suzuki coupling reaction and in other 
catalytic	 transformations of organoboranes,7 it has been found that fluoride additives 
enhance the reactivity of organostannanes. Among our initial scope of different additives, 
KF (2 equiv) was required to maximize the retention/isomerization ratio (Figure 4). 
Figure 4. Solvent and additive effects. 
Other common additives for the Stille coupling are Cu(I) salts which are consid-
ered to play a dual role in the Stille coupling. The effect of the Cu(I) salt in the reaction 
was first discovered by Liebeskind and Fengl.16
 
In their later studies, Cu(I) salts were 
shown to behave as a ligand scavenger as well as a co-catalyst in the reaction.17
 
When the 
reaction is conducted with ligands such as PPh3, Cu(I) can accelerate the reaction by 
Pd(dba)2 (5 mol %)
3 (10 mol %)
CuCl, KF (2 equiv.)
CH3CN, 60 ºC
SnN
CH3
1.2 equiv.
P
OMe
MeO
i-Pri-Pr
i-Pr
CF3
CF3 2
JackiePhos (3)H3C
MeO
Br
MeO
CH3
H3C
MeO
CH3
Retention Isomerization
Additives GC Yield (%)      sBu / n-Bu
No                        15                       4.4
2 equiv. KF           16                       4.9
       2 equiv. CuCl        80                     29.1
  2 equiv. CuCl & KF      85                     57.1
Solvent GC Yield (%)      sBu / n-Bu
Toluene                57                        7.7
Dioxane                84                       12.2
           DME                   20                        6.4
              THF                   47                       12.7
   tBuOH                 84                       40.1
     MeCN                 85                       57.1
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scavenging the ligands tightly bound to the palladium.15  We found that, within our initial 
scope of different additives, 2 equiv of Cu(I) were required to maximize the reten-
tion/isomerization ratio and the yield (Figure 4).  
 
2.3] Substrate scope  
To evaluate the substrate scope accommodated in this reaction, we used 2b in 
cross-coupling reactions with a series of aryl and heteroaryl electrophiles (Figure 5). In 
general, cross-coupling products were obtained with ratios of retention to isomerization 
greater than 50:1. A nominal dependence on the electronic properties of the aryl bromide 
electrophile was observed. Electron-rich, electron-neutral and electron-deficient aryl 
bromides all reacted to give high yields of desired product. Aryl bromides bearing elec-
trophilic functional groups such as aldehydes, ketones, esters, amides and nitriles under-
went successful cross-coupling	 reactions. The presence of an ortho-substituent was also 
well-tolerated. Importantly, heteroaromatic electrophiles could be broadly used without 
significant isomerization of the secondary alkyl nucleophile. Electron-deficient aryl 
chloride electrophiles also underwent efficient cross-coupling reactions under these 
conditions. When a product sample was analyzed by inductively coupled plasma mass 
spectrometry (ICP-MS), only 30 µg/g trace tin was found. This indicates that the stan-
natranes byproducts are easily removed by column chromatography. 
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Figure 5.	 sec-butyl carbastannatrane nucleophile cross couple with a series of aryl and heteroaryl elec-
trophiles. Reaction conditions: aryl halide (1 mmol), carbastannatrane (1.1–1.5 mmol), CuCl (2 mmol), KF 
(2 mmol), Pd(dba)2 (0.05 mmol), Jackiephos (0.06–0.10 mmol), CH3CN (3 ml). Average isolated yield 
(a%) of two runs. Ratio (ret:iso) of retention product (s-Bu) to isomerization product (n-Bu) determined 
by gas chromatography.  
 
To demonstrate the general application of secondary alkylcarbstannatrane nucleo-
philes in Pd-catalyzed reactions, we used a variety of modified alkylcarbastannatranes. 
These substrates were readily generated from 4 using a modified version of the procedure 
developed by Vedejs (Figure 6).8 The judicious choice of solvent allowed secondary 
alkyllithium, alkylmagnesium halide and alkylzinc halide nucleophiles to be used as 
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precursors to the secondary alkylcarbstannatrane reagents. Almost all of the alkylcarba-
stannatranes were air- and moisture-stable and were prepared in excellent yield. We 
successfully employed secondary alkyl groups bearing ethers, amines, esters and amides 
(Figure 7). Secondary benzylic nucleophiles and bis-α-substituted nucleophiles under-
went efficient cross-coupling reactions. During these studies, we also demonstrated that 
the use of aryl triflates and aryl iodides could be tolerated in these reactions. Therefore, 
this cross-coupling reaction appears to be highly general with respect to the nucleophile 
and electrophile employed. 
 
Figure 6. A modified version of the procedure developed by Vedejs.10 
 
	
SnN Cl M
R1
R2
(M = Li, MgX, ZnX)
SnN
R1
R2
• up to 98% yield
• air-stable
• moisture-stable
THF or DMA
4 5
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Figure 7.	secondary alkyl groups bearing ethers, amines, esters and amides. Reaction conditions: aryl 
halide (0.5 mmol), carbastannatrane (0.55–1.0 mmol), CuCl (1 mmol), KF (1 mmol), Pd(dba)2 (0.025 
mmol), Jackiephos (0.03–0.05 mmol), CH3CN (3 ml). Average isolated yield (a%) of two runs. Ratio 
(ret:iso) of retention product (s-Bu) to isomerization product (n-Bu) determined by gas chromatography.	
	
2.4] Use of optically active tin nucleophiles 
    We evaluated the ability of non-racemic alkylcarbstannatrane derivatives to un-
dergo a stereospecific cross-coupling reaction without erosion of the original enantio-
meric excess (e.e.). Using the asymmetric lithiation procedure described by Beak and 
colleagues,
13
 we prepared and isolated optically active 2-stannylpyrrolidine derivative 6 
with 93% e.e. (Figure. 8a). The enantiomers of racemic (rac-6) have also been success-
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fully separated using preparatory chiral high-performance liquid chromatography 
(HPLC). Under ambient conditions, 6 appears to exhibit configurational stability indefi-
nitely. When enantiopure 6 was used in a cross-coupling reaction with 4-
bromobenzonitrile, only nominal erosion of enantiomeric excess was observed in cross-
coupling product 7 (Figure 8b). To determine the absolute stereochemistry of the product, 
we obtained an X-ray crystal structure of a derivative of 7 containing a heavy atom 8 
(Figure 8c). Because it has been well-established that Beak’s (–)-sparteine-mediated 
asymmetric lithiation of pyrrolidine selectively abstracts the pro-S hydrogen of prochiral 
C-1, the X-ray structure confirms that transmetallation occurs with complete retention of 
stereochemistry. 
 It has been shown that the presence of α-heteroatoms and carbonyl coordinating 
groups can activate alkyltin and alkylboron reagents towards stereospecific cross-
coupling reactions.
14
 Therefore, it is conceivable that the successful transfer of stereo-
chemical information in 5 arises as a result of similar activation. To demonstrate that our 
stereospecific cross-coupling method can be used in a general manner for unactivated 
secondary alkyl nucleophiles, we prepared an optically active secondary alkylstan-
natranes (9) without the α-heteroatom or the carbonyl coordinating group. Because heter-
ocyclic electrophiles are generally challenging to employ in cross-coupling reactions, we 
specifically chose 2-bromopyridine and 6-bromo-2-methylquinoline, as well as inactivat-
ed 4-bromoanisole as the electrophilic components in these reactions. When	enantioen-
riched 9 was used in the cross-coupling reactions, minimal erosion of enantiomeric ex-
cess was observed (Figure 9). Moreover, enantioenriched products 10 and 11 indicated 
there is no obvious enantiomeric excess erosion caused by the para-substituent of unacti-
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vated aryl bromides. This suggests that	our process is indeed general and does not require 
the use of an activated secondary alkyl nucleophile or activated aryl bromide. 
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2.5] Conclusion 
In conclusion, the unique features of alkylcarbastannatranes which include easy 
group transfer, specificity, selectivity, and high reactivity, make them highly effective 
reagents for alkyl group transfer in organic synthesis. Stille cross-coupling reactions are 
the emerging application for carbastannatranes, which enable the coupling of the apical 
alkyl substitutent with an aryl electrophile. We have developed the first general stereo-
specific method to use secondary alkylcarbastannane nucleophiles in cross-coupling 
reactions. Using a carbstannatrane backbone, secondary alkyl groups underwent 
transmetallation to palladium with excellent stereofidelity, independent of the electronic 
properties of the alkyl nucleophile. Only nominal isomerization of the secondary alkyl 
nucleophile was observed using this method. Aryl chloride, bromides, iodides and tri-
flates could be efficiently used as the electrophilic component of these cross-coupling 
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Figure 9. Minimal erosion of enantiomeric excess, Enantiospecificity (es) = (eeproduct/eestarting material) x 100%.
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reactions. Furthermore, retention of configuration was observed when an optically active 
secondary alkylcarbstannatrane was used. The benchtop stability of optically active alkyl 
carbstannatrane reagents, coupled with the ease by which stereochemical information 
may be transferred via Pd-catalyzed cross-coupling reactions, should enable our process 
to be broadly applied in organic syntheses, particularly in the preparation of libraries of 
optically active drug candidates. To date, there are few reports on carbastannatranes in 
comparison to other organometallic reagents, which may be due to a lack of sufficient 
and systematic data on this topic. The continued exploration of the potential of carbas-
tannatranes as coupling organometallic reagents will be facilitated by the development of 
new methods for the generation of unactivated alkyl carbstannatranes. 
 
2.6] Experimental information 
 
General Reagent Information 
BDH brand ethyl ether and EMD brand Omnisolv THF (unstabilized) were  pur-
chased from VWR.  These solvents were transferred to separate 20 L solvent-delivery 
kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. s-
BuLi (1.4 M in cyclohexane), isopropylmagnesium chloride (2.0 M in ether), and 5-
chloro-1-aza-5-stannabicyclo[3.3.3]undecane were purchased from Sigma-Aldrich. 
Pd(dba)2 and JackiePhos were purchased from Strem.  Acetonitrile (Sigma-Aldrich) was 
purged with argon prior to use.  Grignard reagents were prepared from their correspond-
ing alkyl chlorides or bromides using a literature procedure.20 Molarities of Grignard 
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reagents were determined using iodine titration.21  Reagents and solvents were used as 
received unless otherwise noted.  Flash chromatography was performed using SiliCylcle 
silica gel (ultra pure grade).    
	
General Analytical Information  
	
All compounds were characterized by 1H NMR and 13C NMR spectroscopy. Cop-
ies of the 1H and 13C spectra for all new compounds can be found at the end of the Sup-
porting Information.  All previously unreported compounds were additionally character-
ized by high resolution MS. Nuclear Magnetic Resonance spectra were recorded on a 
Varian 300 or 500 MHz instrument.  All 1H NMR experiments are reported in δ units, 
parts per million (ppm), and were measured relative to the signals for residual chloroform 
(7.26 ppm).  All 13C NMR spectra are reported in ppm relative to deuterochloroform 
(77.23 ppm), and were obtained with 1H decoupling. High resolution MS analyses were 
performed on an Agilent 6520 Q-TOF instrument.  All GC analyses were performed on a 
Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m x 0.20 mm 
capillary column with cross-linked methyl siloxane as the stationary phase, or using a 30 
m x 0.32 mm chiral column (Rt®-βDEXsm from RESTEK).  All GC yields were calibrat-
ed using dodecane as an internal standard. 
	 	
Procedural Information 
 
General procedure for the preparation of secondary alkyl azastannatranes 
 
All reactions were performed in oven-dried glassware under an atmosphere of Ar.  sec-
Butyllithium or sec-alkyl Grignard reagents (1.5–3.0 equiv) were added to the suspension 
of 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1 equiv) in anhydrous solvent at -78 
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°C. The resulting mixture was stirred at -78 °C for 3 h, allowed to warm to room tem-
perature, and stirred overnight.  The reaction mixture was poured into a separatory funnel 
containing a mixture of water and ether. The organic layer was separated, washed with 
brine, dried over Na2SO4, and filtered. Solvent was removed under reduced pressure and 
dried in vacuo to provide the crude product.  The crude secondary alkyl tin reagents were 
used without further purification.  Homocoupling from Grignard formation constituted 
the major residual byproduct in the crude product. 
	
General procedure for cross-coupling reactions 
 
Pd(dba)2 (5 mol %), JackiePhos (6-10 mol %), CuCl (2 equiv) and KF (2 equiv) were 
weighed out on the benchtop in an oven-dried Schlenk tube with stir bar. With stirring 
begun, the Schlenk tube was evacuated (50 mTorr) and backfilled three times with argon 
using a needle attached to a vacuum manifold. The tin reagent (1.1-2.0 equiv) and aryl 
halide/triflate (1 equiv) was then added to the Schlenk tube via microsyringe, followed by 
degassed CH3CN (3 mL for 0.5-1.0 mmol scale). If the aryl halide/triflate was a solid, it 
was weighed out on the benchtop alongside the other solids. The Schlenk tube was sealed 
and heated to 60 °C for 18 h. The reaction mixture was cooled to rt, diluted with ether, 
washed sequentially with saturated aqueous KF and brine, and dried over Na2SO4. The 
reaction solution was filtered and concentrated to provide the crude product.  The crude 
product was purified by column chromatography. 
 
Synthesis	of		8		for	absolute	configuration	determination	via	x-ray	crystallography	
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Single Crystal Structure Determination  
	
Experimental Description 
	
A colorless slab-like crystal with the size of 0.05 × 0.20 × 0.54 mm3 was selected for 
geometry and intensity data collection with a Bruker SMART APEXII CCD area detector 
on a D8 goniometer at 100 K. The temperature during the data collection was controlled 
with an Oxford Cryosystems Series 700+ instrument. Preliminary lattice parameters and 
orientation matrices were obtained from three sets of frames. Data were collected using 
graphite-monochromated and 0.5 mm-MonoCap-collimated Mo-Kα radiation (λ = 
0.71073 Å) with the ω scan method.22 Data were processed with the INTEGRATE pro-
gram of the APEX2 software22 for reduction and cell refinement. Multi-scan absorption 
corrections were applied by using the SCALE program for the area detector. The struc-
ture was solved by the direct method and refined on F2 (SHELXTL).23 Non-hydrogen 
atoms were refined with anisotropic displacement parameters, and hydrogen atoms on 
carbons were placed in idealized positions (C-H = 0.95-1.00 Å) and included as riding 
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with Uiso(H) = 1.2 Ueq(non-H), and the hydrogen atoms on the oxygen atoms were 
refined with a restrained O-H distance of 0.83 Å. 
	
 
Crystal Structure of 8 
 
 
 
 
 
 
Compound Characterization 
	
	 	
	
	
5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane.24 The general procedure was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2.94 g, 10.0 mmol) in 
ether (40 mL), and s-BuLi (1.4 M in cyclohexane, 16 mL, 22.4 mmol). A yellow oil (3.18 
g, 99%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.64 (quint, J 
= 6 Hz, 6H), 1.41-1.51 (m, 3H), 1.05 (d, J = 7.5 Hz, 3H), 0.86 (t, J = 7 Hz, 3H), 0.63 (t, J 
= 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 55.0, 29.4, 26.7, 23.7, 18.5, 14.8, 5.7 
ppm.		
SnN
CH3
H3C
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5-(iso-Propyl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.47 g, 5.0 mmol) in 
ether (20 mL), and isopropylmagnesium chloride (2.0 M in ether, 7.5 mL, 15 mmol). A 
yellow oil (1.41 g, 95%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.38 (t, J = 6 Hz, 
6H), 1.67 (quint, J = 6 Hz, 6H), 1.09 (d, J = 7.5 Hz, 6H), 0.70-0.76 (m, 1H), 0.65 (t, J = 
6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 54.9, 23.6, 21.6, 17.7, 4.6 ppm. HRMS 
(FAB+): Calcd (116Sn) (M-H)+ 298.0926; Found (116Sn) 298.0929. 
	
	
	
	
5-(1-Methylpiperidin-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general proce-
dure was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.06 g, 3.6 
mmol) in THF (36 mL), and (1-methylpiperidin-4-yl)magnesium chloride (0.78 M in 
THF, 7 mL, 5.5 mmol).  A pale yellow solid (1.25 g, 97%) was isolated. 1H NMR (500 
MHz, CDCl3) δ: 2.76 (br. s, 2H), 2.34 (t, J = 6 Hz, 6H), 2.19 (s, 3H), 1.55-1.79 (m, 13H), 
0.63 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 59.0, 54.8, 47.3, 30.8, 26.2, 
23.5, 4.7 ppm. HRMS (FAB+): Calcd (116Sn) (M-H)+ 353.1348; Found (116Sn) 353.1356. 
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5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general 
procedure was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 
3.0 mmol) in THF (30 mL), and (tetrahydro-2H-pyran-4-yl)magnesium chloride (0.62 M 
in THF, 7 mL, 4.3 mmol). A pale yellow solid (983 mg, 95%) was isolated. 1H NMR 
(500 MHz, CDCl3) δ: 3.87 (m, 2H), 3.33 (dt, J = 11, 2 Hz, 2H), 2.36 (t, J = 6 Hz, 6H), 
1.64 (quint, J = 6 Hz, 6H), 1.50-1.55 (m, 4H), 0.89-0.95 (m, 1H), 0.64 (t, J = 6.5 Hz, 6H) 
ppm. 13C NMR (125 MHz, CDCl3) δ: 71.0, 54.8, 31.3, 26.0, 23.4, 4.6 ppm. HRMS 
(FAB+): Calcd (116Sn) (M-H)+ 340.1031; Found (116Sn) 340.1025. 
	
	
	
	
5-(1-Phenylethyl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (140 mg, 0.48 mmol)  in 
THF (5 mL), and (1-phenylethyl)magnesium chloride (0.21 M in THF, 3 mL, 0.63 
mmol). A yellow liquid (146 mg, 92%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.15 
(t, J = 7.5 Hz, 2H), 6.90 (m, 3H), 2.30 (t, J = 6 Hz, 6H), 2.21 (quart, J = 7.5, 1H), 1.61 
(quint, J = 6 Hz, 6H), 1.44 (d, J = 7.5 Hz, 3H), 0.61 (dt, J = 6.5, 3 Hz, 6H) ppm. 13C 
NMR (125 MHz, CDCl3) δ: 151.5, 128.0, 124.9, 121.7, 54.7, 32.7, 23.5, 16.7, 5.3 ppm. 
HRMS (FAB+): Calcd (116Sn) (M-H)+ 360.1082; Found (116Sn) 360.1072. 
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5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.65 g, 5.6 mmol) 
in THF (50 mL), and (4-phenylbutan-2-yl)magnesium chloride (0.28 M in THF, 23 mL, 
6.4 mmol).  A yellow liquid (1.74 g, 79%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 
7.25-7.28 (m, 2H), 7.16-7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t, J = 6 Hz, 6H), 1.76-
1.81 (m, 1H), 1.65 (quint, J = 6 Hz, 6H), 1.23-1.39 (m, 1H), 1.13 (d, J = 7.5 Hz, 3H), 
0.79 (quart, J = 7.5 Hz, 1H), 0.67 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) 
δ: 143.9, 128.6, 128.3, 125.5, 54.9, 39.0, 36.5, 24.2, 23.6, 18.6, 5.6 ppm. HRMS (FAB+): 
Calcd (116Sn) (M-H)+ 388.1396; Found (116Sn) 388.1409. 
	
	
	
	
5-(Octan-3-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.74 g, 2.5 mmol) in 
THF (25 mL), and octan-3-ylmagnesium chloride (0.35 M in THF, 11 mL, 3.8 mmol). A 
colorless liquid (190 mg, 51%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.36 (t, J = 6 
Hz, 6H), 1.64 (quint, J = 6 Hz, 6H), 1.43-1.47 (m, 1H), 1.20-1.30 (m, 10H), 0.88 (t, J = 7 
Hz, 3H), 0.84 (t, J = 7.5 Hz, 3H), 0.64 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, 
CDCl3) δ: 55.1, 34.0, 33.3, 32.6, 29.9, 26.3, 23.8, 23.0, 14.7, 14.4, 6.9 ppm. HRMS 
(FAB+): Calcd (116Sn) (M-H)+ 368.1708; Found (116Sn) 368.1698. 
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Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate.  The general procedure 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 mmol) 
in DMF (8 mL), and (4-ethoxy-4-oxobutan-2-yl)zinc iodide (0.61 M in DMF, 10 mL, 6.1 
mmol). An orange oil (509 mg, 45%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 4.09 
(quart, J = 7 Hz, 2H), 2.39-2.43 (m, 1H), 2.35 (t, J = 6 Hz, 6H), 2.23-2.27 (m, 1H), 1.64 
(quint, J = 6 Hz, 6H), 1.24 (t, J = 7 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J = 6.5 Hz, 6H) 
ppm. 13C NMR (125 MHz, CDCl3) δ: 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 18.4, 14.6, 5.2 
ppm. HRMS (FAB+): Calcd (116Sn) (M-H)+ 370.1138; Found (116Sn) 370.1136. 
	
	
	
	
tert-Butyl 2-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)pyrrolidine-1-carboxylate. 
TMEDA (0.8 mL, 5.5 mmol) in ether (1 mL) was precooled to -78 ºC for 15 min.  s-BuLi 
(1.4 M in cyclohexane, 4 mL, 5.6 mmol) was added dropwise to this solution.  The result-
ing solution was allowed to stir for 15 min.  A solution of N-Boc-pyrrolidine (855 mg, 
5.0 mmol) in ether (10 mL) was then added dropwise.  This reaction mixture was stirred 
at -78 ºC for 3h. The resulting solution (1-tert-butoxycarbonyl)pyrrolidin-2-yl)lithium 
(0.22 M in ether, 17 mL, 3.74 mmol)6 was employed in the general procedure with 5-
chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.74 g, 2.5 mmol) in ether (25 mL).  A 
yellow oil (854 mg, 80%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 3.11-3.34 (m, 
2H), 2.32-2.38 (m, 6H), 2.01-2.21 (m, 1H), 1.63-1.70 (m, 10H), 1.47 (s, 4H), 1.43 (s, 
5H), 0.70-0.73 (m, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 154.0, 77.9, 55.2, 51.4, 
N
Boc
Sn N
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46.7, 30.3, 28.9, 27.2, 23.7, 7.0 ppm. HRMS (FAB+): Calcd (116Sn) (M-H)+ 425.1559; 
Found (116Sn) 425.1560. 
	
	
	
(S)-tert-Butyl 2-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)pyrrolidine-1-
carboxylate. (-)-Sparteine (258 mg, 1.1 mmol) in ether (1 mL) was precooled to -78 ºC 
for 15 min.  s-BuLi (1.4 M in cyclohexane, 0.8 mL, 1.12 mmol) was added dropwise to 
the solution. The resulting solution was allowed to stir for 15 min.  A solution of N-Boc-
pyrrolidine (171 mg, 1.0 mmol) in ether (2 mL) was then added dropwise. This mixture 
was stirred at -78 ºC for 3 h. The resulting (1-tert-butoxycarbonyl)pyrrolidin-2-yl)lithium 
solution (0.23 M in ether, 4 mL, 0.9 mmol)6 was employed in the general procedure with 
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.18 g, 0.6 mmol) in ether (6 mL), and 
(1-tert-butoxycarbonyl)pyrrolidin-2-yl)lithium. A yellow oil (160 mg, 62%, 93% ee) was 
isolated. 1H NMR (500 MHz, CDCl3) δ: 3.11-3.34 (m, 2H), 2.32-2.38 (m, 6H), 2.01-2.21 
(m, 1H), 1.63-1.70 (m, 10H), 1.47 (s, 4H), 1.43 (s, 5H), 0.70-0.73 (m, 6H) ppm. 13C 
NMR (125 MHz, CDCl3) δ: 154.0, 77.9, 55.2, 51.4, 46.7, 30.3, 28.9, 27.2, 23.7, 7.0 ppm. 
	
	
	
	
	
Ethyl 4-(sec-butyl)benzoateref (Table 1, row 1, column 1). The general procedure was 
employed using ethyl 4-bromobenzoate (229 mg, 1 mmol), 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), and JackiePhos (48 mg, 0.06 mmol). 
N
Boc
Sn N
EtO2C
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A colorless liquid (174 mg, 77%) was isolated by column chromatography (98:2 
Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.97 (d, J = 2 Hz, 2H), 7.24 (d, J = 2 Hz, 
2H), 4.36 (m, 2H), 2.65 (m, 1H), 1.61 (m, 2H), 1.38 (t, J = 7 Hz, 3H), 1.24 (d, J = 6.5 Hz, 
3H), 0.81 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 166.8, 153.2, 129.8, 
128.3, 127.2, 60.8, 41.9, 31.0, 21.7, 14.5, 12.3 ppm. 
	
	
	
	
1-(sec-Butyl)-4-methoxybenzeneref (Table 1, row 1, column 2). The general procedure 
was employed using 1-bromo-4-methoxybenzene (187 mg, 1 mmol), 5-(sec-butyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 mmol). 
A colorless liquid (124.7 mg, 77%) was isolated by column chromatography (97:3 
Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.11 (d, J = 8.5, 2H), 6.86 (d, J = 9 Hz, 2H), 
3.80 (s, 3H), 2.56 (m, 1H), 1.58 (m, 2H), 1.23(d, J = 7 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) 
ppm. 13C NMR (125 MHz, CDCl3) δ: 157.9, 140.0, 128.0, 113.8, 55.4, 41.0, 31.5, 22.2, 
12.4 ppm. 
	
	
	
	
4-(sec-Butyl)-N,N-dimethylanilineref (Table 1, row 1, column 3). The general procedure 
was employed using 4-bromo-N,N-dimethylaniline (200 mg, 1 mmol), 5-(sec-butyl)-1-
aza-5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 
mmol). An oily, brown solid (110 mg, 62%) was isolated by column chromatography 
s-Bu
MeO
s-Bu
Me2N
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(99:1 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.08 (d, J = 8.5 Hz, 2H), 6.73 (d, J = 
8.5 Hz, 2H), 2.93 (s, 6H), 2.52 (m, 1H), 1.57 (m, 2H), 1.22 (d, J = 7 Hz, 3H), 0.84 (t, J = 
8.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 149.2, 136.2, 127.8, 113.1, 41.1, 40.8, 
31.6, 22.2, 12.5 ppm. 
	
	
	
	
3-(sec-Butyl)benzaldehyde (Table 1, row 2, column 1). The general procedure was 
employed using 3-bromobenzaldehyde (185 mg, 1 mmol), 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), and JackiePhos (48 mg, 0.06 mmol). 
A oily, yellow liquid (120.1 mg, 74%) was isolated by column chromatography (98.5:1.5 
Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 10.00 (s, 1H), 7.70 (m, 2H), 7.46 (m, 2H), 
7.04 (s, 1H), 2.69 (m, 1H), 1.63 (m, 2H), 1.27(d, J = 7 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) 
ppm. 13C NMR (125 MHz, CDCl3) δ: 192.8, 149.0, 136.8, 133.7, 129.1, 128.2, 128.0, 
41.7, 31.2, 21.9, 12.3 ppm. HRMS (EI+): Calcd (M+) 162.1045; Found 162.1047. 
	
	
	
	
1-(sec-Butyl)-3,5-dimethylbenzeneref (Table 1, row 2, column 2). The general procedure 
was employed using 1-bromo-3,5-dimethylbenzene (185 mg, 1 mmol), 5-(sec-butyl)-1-
aza-5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 
mmol).  A colorless liquid (128 mg, 77%) was isolated by column chromatography 
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(97.5:2.5 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 6.82 (m, 3H), 2.52 (m, 1H), 2.31 (s, 
6H), 1.59 (m, 2H), 1.22 (d, J = 6.5 Hz, 3H), 0.84 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 
MHz, CDCl3) δ: 160.5, 148, 137.8, 127.7, 125.1, 41.8, 31.4, 22.1, 21.6, 12.6 ppm. 
	
	
	
	
1-(sec-Butyl)-2,4-dimethylbenzeneref (Table 1, row 2, column 3). The general procedure 
was employed using 1-bromo-2,4-dimethylbenzene (185 mg, 1 mmol), 5-(sec-butyl)-1-
aza-5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 
mmol).  A colorless liquid (125 mg, 74%) was isolated by column chromatography 
(97.5:2.5 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.08 (d, J = 8 Hz, 1H), 6.98 (m, 
2H), 2.84 (m, 1H), 2.29 (s, 6H), 1.58 (m, 2H), 1.18 (d, J = 6.5 Hz, 3H), 0.86 (t, J = 7.5 
Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.1, 135.5, 134.9, 131.2, 127.0, 125.4, 
36.1, 30.8, 21.5, 21.1, 19.7, 12.5 ppm. 
	
	
	
	
1-(sec-Butyl)-3-(trifluoromethoxy)benzene (Table 1, row 3, column 1). The general 
procedure was employed using bromo-3-(trifluoromethoxy)benzene (241 mg, 1 mmol), 
5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), JackiePhos (48 
mg, 0.06 mmol).  A colorless liquid (152.4, 73%) was isolated by column chromatog-
raphy (98.5:1.5 Hex/Ether). 1H NMR (500 MHz CDCl3) δ: 7.30 (t, J = 8 Hz, 1H), 7.18 (d, 
J = 7.5 Hz, 1H), 7.04 (s, 1H), 7.02 (s, 1H), 2.62 (m,1H), 1.59 (m, 2H), 1.24 (d, J = 6.5 
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Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 150.3, 129.7, 
125.7, 119.8, 118.3, 41.7, 31.2, 21.8, 12.3 ppm. HRMS (EI+): Calcd (M+) 218.0918; 
Found 218.0919. 
	
	
	
	
1-(sec-Butyl)-4-nitrobenzeneref (Table 1, row 3, column 2). The general procedure was 
employed using 1-chloro-4-nitrobenzene (158 mg, 1 mmol), 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 mmol). 
An oily, yellow liquid (168 mg, 93%) was isolated by column chromatography (99:1 
Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 8.15 (d, J = 9 Hz, 2H), 7.33 (d, J = 8.5 Hz, 
2H), 2.73 (M, 1H), 1.63 (m, 2H), 1.27 (d, J = 7 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3) δ: 155.7, 146.5, 128.1, 123.8, 42.0, 31.1, 21.7, 12.3 ppm. 
	
	
	
	
4-(sec-Butyl)benzonitrileref (Table 1, row 3, column 3). The general procedure was 
employed using 4-chlorobenzonitrile (138 mg, 1 mmol), 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 mmol).  
An oily, yellow solid (125.8 mg, 79%) was isolated by column chromatography (99:1 
Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.59 (d, J = 8 Hz, 2H), 7.29 (d, J = 8.5 Hz, 
2H), 2.67 (M, 1H), 1.61 (m, 2H), 1.25 (d, J = 7 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) ppm. 
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13C NMR (125 MHz, CDCl3) δ: 153.5, 132.4, 128.1, 119.4, 109.8, 42.1, 31.0, 21.6, 12.2 
ppm. 
	
	
	
	
1-(5-(sec-Butyl)benzofuran-2-yl)ethanone (Table 1, row 4, column 1). The general 
procedure was employed using 1-(5-bromobenzofuran-2-yl)ethanone (239 mg, 1 mmol), 
5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), and JackiePhos 
(48 mg, 0.06 mmol). A pale yellow solid (175 mg, 82%) was isolated by column chroma-
tography (97:3 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.48 (m, 3H), 7.31 (m, 1H), 
2.71 (m, 1H), 2.6 (s, 3H), 1.63 (m, 2H), 1.28 (d, J = 7 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) 
ppm. 13C NMR (125 MHz, CDCl3) δ: 188.9, 165.3, 154.7, 143.8, 128.2, 127.3, 121.1, 
113.3, 112.3, 41.8, 31.7, 26.6, 22.5, 12.4 ppm. HRMS (EI+): Calcd (M+) 216.1150; Found 
216.1141. 
	
	
	
	
6-(sec-Butyl)-2H-benzo[b][1,4]oxazin-3(4H)-oneref (Table 1, row 4, column 2). The 
general procedure was employed using 6-bromo-2H-benzo[b][1,4]oxarin-3(4H)-one (228 
mg, 1 mmol), 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), 
and JackiePhos (80 mg, 0.1 mmol).  A pale yellow solid (133 mg, 67%) was isolated by 
column chromatography (80:20 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 9.43 (br s, 
1H) 6.89 (d, J = 8 Hz, 1H), 6.79 (dd, J = 8, 2 Hz, 1H), 6.65 (s, 1H), 4.61(s, 2H), 2.53 (m, 
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1H), 1.55 (m, 2H), 1.20 (d, J = 7 Hz, 3H), 0.81 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 
MHz, CDCl3) δ: 167.3, 142.8, 141.8, 126.0, 122.7, 116.5, 115.0, 67.3, 41.2, 31.3, 22.1, 
12.4 ppm. 
	
	
	
	
3-(sec-Butyl)benzo[b]thiopheneref (Table 1, row 4, column 3). The general procedure 
was employed using 3-bromobenzo[b]thiophene (213 mg, 1 mmol), 5-(sec-butyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 mmol).  
A colorless liquid (85.5 mg, 45%) was isolated by column chromatography (99:1 
Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.87 (d, J = 7.5 Hz, 1H), 7.80 (d, J = 8 Hz, 
1H), 7.37 (m, 2H), 7.09 (s, 1H), 3.12 (m, 1H), 1.86 (m, 1H), 1.68 (m, 1H), 1.37 (d, J = 7 
Hz, 3H), 0.95 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 142.7, 140.9, 
139.0, 124.2, 123.8, 123.1, 122.1, 119.7, 34.8, 30.0, 20.5, 12.2 ppm. 
 
	
	
	
1-(4-(sec-Butyl)phenyl)-1H-pyrroleref (Table 1, row 5, column 1). The general proce-
dure was employed using 1-(4-bromophenyl)-1H-pyrrole (222 mg, 1 mmol), 5-(sec-
butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), and JackiePhos (48 
mg, 0.06 mmol). A brown liquid (131 mg, 77%) was isolated by column chromatography 
(99:1 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.32 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 
8.5 Hz, 2H), 7.08 (t, J = 2 Hz, 2H), 6.35 (t, J = 2 Hz, 2H),  2.64 (m, 1H), 1.62 (m, 2H), 
S
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1.27 (d, J = 7 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 
145.4, 138.9, 128.2, 120.8, 119.6, 110.2, 41.3, 31.4, 22.1, 12.4 ppm.  
	
	
	
	
6-(sec-Butyl)-2-methylquinoline (Table 1, row 5, column 2). The general procedure was 
employed using 6-bromo-2-methylquinoline (222 mg, 1 mmol), 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (348 mg, 1.1 mmol), and JackiePhos (48 mg, 0.06 mmol). 
A yellow liquid (172 mg, 86%) was isolated by column chromatography (95:5 
Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.97 (m, 2H), 7.53 (m, 2H), 7.24 (d, J = 8.5 
Hz, 1H), 2.77 (m, 1H), 2.72 (s, 3H), 1.68 (m, 2H), 1.32 (d, J = 6 Hz, 3H), 0.84 (t, J = 7.5 
Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 158.2, 147.1, 145.2, 136.0, 129.6, 128.7, 
126.7, 124.9, 122.0, 41.8, 31.3, 25.5, 22.0, 12.4 ppm. HRMS (EI+): Calcd (M+) 199.1361; 
Found 199.1359. 
	
	
	
	
2-(sec-Butyl)-6-methoxypyridine (Table 1, row 5, column 3). The general procedure 
was employed using 2-bromo-6-methoxypyridine (188 mg, 1 mmol), 5-(sec-butyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (475 mg, 1.5 mmol), and JackiePhos (80 mg, 0.1 mmol).  
A colorless liquid (92.5 mg, 56%) was isolated by column chromatography (99:1 
Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.46 (t, J = 7.5 Hz, 1H), 6.67 (d, J = 7.5 Hz, 
1H), 6.52 (d, J = 8 Hz, 2H), 3.91(s, 3H), 2.66 (M, 1H), 1.76 (m, 1H), 1.57 (m, 1H),  1.25 
(d, J = 6.5 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 164.6, 
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163.8, 138.7, 114.3, 107.3, 53.3, 43.4, 29.8, 20.4, 12.3 ppm. HRMS (EI+): Calcd (M+) 
165.1154; Found 165.1154. 
	
	
	
	
3-Isopropylbenzo[b]thiopheneref (Table 2, row 1, column 1). The general procedure 
was employed using 3-bromobenzo[b]thiophene (107 mg, 0.5 mmol), 5-(iso-Propyl)-1-
aza-5-stannabicyclo[3.3.3]undecane (166 mg, 0.55 mmol), and JackiePhos (24 mg, 0.03 
mmol).  A colorless liquid (125 mg, 71%) was isolated by column chromatography 
(99.5:0.5 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.86 (dd, J = 8, 0.5 Hz, 1H), 7.80 
(dd, J = 8, 0.5 Hz, 1H), 7.36 (m, 2H), 7.10 (s, 1H), 3.32 (septet, J = 7 Hz, 1H), 1.39 (d, J 
= 7 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.9, 141.0, 138.8, 124.3, 123.9, 
123.1, 122.1, 119.1, 28.1, 23.0 ppm. 
	
	
	
	
1-(5-(Tetrahydro-2H-pyran-4-yl)benzofuran-2-yl)ethanone (Table 2, row 1, column 
2). The general procedure was employed using 1-(5-bromobenzofuran-2-yl)ethanone 
(120 mg, 0.5 mmol), 5-(tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(189 mg, 0.55 mmol), and JackiePhos (24 mg, 0.03 mmol).   A brown solid (103 mg, 
85%) was isolated by column chromatography (70:30 Hex/Ether). 1H NMR (500 MHz, 
CDCl3) δ: 7.53 (m, 2H), 7.47 (s, 1H), 7.36 (dd, J = 8.5, 1.5 Hz, 1H), 4.12 (dd, J = 11, 4 
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Hz, 2H), 3.55 (td, J = 11.5, 2.5 Hz, 2H), 2.86 (m, 1H), 2.61 (s, 3H), 1.85 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3) δ: 188.5, 154.6, 153.0, 141.9, 127.8, 127.3, 120.6, 113.1, 
112.4, 68.4, 41.5, 34.4, 26.5 ppm. HRMS (FAB+): Calcd (M+H)+ 245.1178; Found 
245.1187. 
	
	
	
	
Ethyl 3-(4-(1H-pyrrol-1-yl)phenyl)butanoate (Table 2, row 1, column 3). The general 
procedure was employed using 1-(4-bromophenyl)-1H-pyrrole (111 mg, 0.5 mmol), and 
ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (206 mg, 0.55 mmol), and 
JackiePhos (24 mg, 0.03 mmol).  A reddish brown oil 104 mg, 81%) was isolated by 
column chromatography (92:8 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.27-7.33 (m, 
4H), 7.06 (t, J = 2 Hz, 2H), 6.33 (t, J = 2 Hz, 2H), 4.09 (m, 2H), 3.31 (m, 1H), 2.59 (m, 
2H), 1.32 (d, J = 7 Hz, 3H), 1.19 (t, J = 7 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 
172.4, 143.4, 139.4, 128.1, 120.9, 119.5, 110.4, 60.5, 43.2, 36.2, 22.1, 14.4 ppm. HRMS 
(FAB+): Calcd (M+) 257.1416; Found 257.1424. 
	
	
	
	
2-Methyl-6-(octan-3-yl)quinoline (Table 2, row 2, column 1). The general procedure 
was employed using 6-bromo-2-methylquinoline (111 mg, 0.5 mmol), 5-(octan-3-yl)-1-
aza-5-stannabicyclo[3.3.3]undecane (279 mg, 0.75 mmol), and JackiePhos (40 mg, 0.05 
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mmol). An oily, yellow solid (128 mg, 100%) was isolated by column chromatography 
(80:20 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.96 (t, J = 9 Hz, 2H), 7.50 (dd, J = 
8.5, 2 Hz, 1H), 7.47 (s, 1H), 7.23 (d, J = 8 Hz, 1H), 2.72 (s, 3H), 2.56 (m, 1H), 1.57-1.83 
(m, 4H), 1.15-1.27 (m, 6H), 0.80 (t, J = 6.5 Hz, 3H), 0.76 (t, J = 7.5 Hz, 3H) ppm. 13C 
NMR (125 MHz, CDCl3) δ: 158.2, 147.1, 143.7, 136.0, 129.7, 128.6, 126.6, 126.0, 122.0, 
48.0, 36.7, 32.2, 29.8, 27.5, 25.5, 22.7, 14.3, 12.4 ppm. HRMS (FAB+): Calcd (M+H)+ 
256.2065; Found 256.2063. 
	
	
	
	
1-Nitro-4-(1-phenylethyl)benzeneref (Table 2, row 2, column 2). The general procedure 
was employed 1-bromo-4-nitrobenzene (101 mg, 0.5 mmol), 5-(1-phenylethyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (273 mg, 0.75 mmol), and JackiePhos (40 mg, 0.05 mmol).  
A brownish liquid (104.5 mg, 92%) was isolated by column chromatography (99:1 
Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 8.18 (m, 2H), 7.41-7.22 (m, 7H), 4.29 (quar-
tet, J = 7.5 Hz, 1H), 1.72 (d, J = 7.5 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 154.2, 
146.6, 144.7, 128.9, 128.6, 127.7, 126.9, 123.9, 44.9, 21.7 ppm. HRMS (EI+): Calcd (M+) 
227.0946; Found 227.0947. 
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Ethyl 4-(1-methylpiperidin-4-yl)benzoate (Table 2, row 2, column 3). The general 
procedure was employed using ethyl 4-bromobenzoate (115 mg, 0.5 mmol), 5-(1-
methylpiperidin-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (268 mg, 0.75 mmol), and 
JackiePhos (40 mg, 0.05 mmol).  A brown solid (94 mg, 76%) was isolated by column 
chromatography (91:9 CH2Cl2/MeOH). 1H NMR (500 MHz, CDCl3) δ: 7.95 (d, J = 8 Hz, 
2H), 7.28 (d, J = 8.5 Hz, 2H), 4.33 (m, 2H), 3.27 (d, J = 6 Hz, 2H), 2.65 (m, 1H), 2.56 (s, 
3H), 2.48 (t, J = 11 Hz, 2H), 2.15 (m, 2H), 1.91 (d, J = 13 Hz, 2H), 1.35 (t, J = 7 Hz, 3H), 
1.22 (s, 1H) ppm. 13C NMR (125 MHz, CDCl3) δ: 166.5, 149.7, 130.1, 129.2, 127.0, 
61.0, 55.6, 45.1, 41.1, 31.6, 14.5 ppm. HRMS (FAB+): Calcd (M+H)+ 248.1651; Found 
248.1655. 
	
	
	
6-Isopropylquinolineref (Table 2, row 3, column 1). The general procedure was em-
ployed using quinolin-6-yl trifluoromethanesulfonate (139 mg, 0.5 mmol), 5-(iso-
propyl)-1-aza-5-stannabicyclo[3.3.3]undecane (166 mg, 0.55 mmol), and JackiePhos (24 
mg, 0.03 mmol).   A yellow liquid (74.2 mg, 88%) was isolated by column chromatog-
raphy (90:10 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.68 (d, J = 8.5 Hz, 2H), 7.23 
(d, J = 8 Hz, 2H), 6.66 (s, 1H), 5.16 (br s, 2H), 2.92 (septet, J = 8.5 Hz, 1H), 1.26 (d, J = 
8.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 149.8, 147.4, 147.3, 135.9, 129.6, 
129.5, 128.5, 124.0, 121.2, 34.3, 24.0 ppm. 
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5-Isopropyl-1H-indoleref (Table 2, row 3, column 2). The general procedure was em-
ployed using 3-iodo-1H-indole (122 mg, 0.5 mmol), 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (166 mg, 0.55 mmol), and JackiePhos (24 mg, 0.03 mmol).   
A reddish brown solid (48 mg, 60%) was isolated by column chromatography (92:8 
Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 8.05 (br s, 1H), 7.49 (s, 1H), 7.33 (d, J = 8 
Hz, 1H), 7.18 (t, J = 3 Hz, 1H), 7.10 (dd, J = 8.5, 1.5 Hz, 1H), 6.51 (m, 1H), 3.02 (septet, 
J = 7 Hz, 1H), 1.31 (d, J = 7 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 140.7, 134.5, 
128.2, 124.5, 121.5, 117.8, 111.0, 102.6, 34.4, 24.9 ppm. 
	
	
	
	
1,3-Dimethyl-5-(4-phenylbutan-2-yl)benzeneref (Table 2, row 3, column 3). The gen-
eral procedure was employed using 1-bromo-3,5-dimethylbenzene (93 mg, 0.5 mmol), 5-
(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (294 mg, 0.75 mmol), and 
JackiePhos (40 mg, 0.05 mmol).  A colorless liquid (104 mg, 87%) was isolated by col-
umn chromatography (99.7:0.3 Hex/Ether). 1H NMR (500 MHz, CDCl3) δ: 7.30 (t, J = 7 
Hz, 2H), 7.19 (t, J = 6.5 Hz, 3H), 6.88 (s, 1H), 6.86 (s, 2H), 2.69 (m, 1H), 2.60 (m, 2H), 
2.35 (s, 6H), 1.95 (m, 2H), 1.30 (d, J = 7 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ: 
147.6, 142.9, 138.0, 128.6, 128.4, 127.8, 125.8, 125.1, 40.2, 39.6, 34.3, 22.7, 21.6 ppm. 
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4-(4-Isopropylphenyl)thiazol-2-amineref (Table 2, row 4, column 1). The general pro-
cedure was employed using 4-(4-bromophenyl)thiazol-2-amine (128 mg, 0.5 mmol), 5-
(iso-propyl)-1-aza-5-stannabicyclo[3.3.3]undecane (302 mg, 1 mmol), and JackiePhos 
(40 mg, 0.05 mmol).  A brown oil (30.5 mg, 28%) was isolated by column chromatog-
raphy (75:25 Hex/EtOAc). 1H NMR (500 MHz, CDCl3) δ: 7.68 (d, J = 8.5 Hz, 2H), 7.23 
(d, J = 8 Hz, 2H), 6.66 (s, 1H), 5.16 (br s, 2H), 2.92 (septet, J = 8.5 Hz, 1H), 1.26 (d, J = 
8.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 167.5, 151.6, 148.8, 132.5, 126.9, 
126.2, 102.3, 34.1, 24.1 ppm. 
	
	
	
 
tert-Butyl 2-(4-cyanophenyl)pyrrolidine-1-carboxylate25 (Table 2, row 4, column 2). 
The general procedure was employed using 4-bromobenzonitrile (91 mg, 0.5 mmol) tert-
butyl 2-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)pyrrolidine-1-carboxylate (429 mg, 1 
mmol), and JackiePhos (40 mg, 0.05 mmol).  A white solid (85 mg, 63%) was isolated by 
column chromatography (70:30 Hex/Ether). 1H NMR (500 MHz, CDCl3) (two rotamers 
in a ratio of 3:2 were observed – major rotomer given) δ: 7.60 (d, J = 8 Hz, 2H), 7.28 (d, 
J = 8.5 Hz, 2H), 4.80 (m, 1H), 3.63 (m, 1H), 2.37 (m, 1H), 1.78-1.89 (m, 3H), 1.18-1.22 
(m, 9H) ppm. 13C NMR (125 MHz, CDCl3) (two rotamers were observed – minor ro-
tomer in parentheses) δ: 154.3 (154.3), 151.0 (149.0), 132.3 (132.4), 126.4 (126.4), 119.1 
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(119.1), 110.6 (110.6), 79.9 (83.0), 61.3 (60.3), 47.3 (48.3), 36.1 (34.1), 28.3 (28.3), 23.4 
(23.7) ppm. 
 
Optically active stannatrane (6) prepared using Beak’s enantioselective deprotonation 
method 
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Separation of enantiomers of 6 via preparatory chiral HPLC 
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Chiral GC of cross-coupling reaction using 99% ee pyrrolidine stannatrane (6) (after 
Boc deprotection) 
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Separation of enantiomers of 5-(4-Phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane via preparatory chiral HPLC 
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HPLC of product  from reactions of Figure 8 
 
	
	
	
	
	
	
CH3
N
91.2% ee
CH3
N
racemic
	
	
CH3
racemic
N
CH3
91.7% ee
N
	 60	
	 25
S25 
	 61	
	
26
S26 
Sn
N
CH
3
CH
3
	 62	
	
27
S27 
	 63	
	
28
S28 
	 64	
	
29
S29 
	 65		
30
S30 
	 66	
	
31
S31 
	 67	
	
32
S32 
	 68	
	
33
S33 
	 69	
	
34
S34 
	 70	
	
35
S35 
	 71	
	
36
S36 
	 72	
	
37
S37 
	 73	
	
38
S38 
	 74	
	
39
S39 
	 75	
	
40
S40 
	 76	
	
41
S41 
	 77	
	
42
S42 
	 78	
	
43
S43 
	 79	
	
44
S44 
	 80	
	
45
S45 
	 81	
	
46
S46 
O
M
eO
s-
Bu
	 82	
	
47
S47 
	 83	
	
48
S48 
	 84	
	
49
S49 
	 85	
	
50
S50 
	 86	
	
51
S51 
	 87	
	
52
S52 
	 88	
	
53
S53 
	 89	
	
54
S54 
	 90	
	
55
S55 
	 91	
	
56
S56 
	 92	
	
57
S57 
	 93	
	
58
S58 
	 94	
	
59
S59 
	 95	
	
60
S60 
	 96	
	
61
S61 
C
H
3
N
91
.3
%
 e
e*
	 97	
	
62
S62 
C
H
3
N
91
.3
%
 e
e*
	 98	
	
63
S63 
C
H
3
N
C
H
3 *
91
.9
%
 e
e
	 99	
 
 
64
S64 
C
H
3
N
C
H
3 *
91
.9
%
 e
e
	 100	
2.7] References 
1. (a) Farina, A., Pure Appl. Chem. 1996, 68, 73. (b) Brown, J. M.; Pearson, M.; Ja-
strzebski, J. T. B. H.; Koten, G. V., J. Chem. Soc. 1992, 1440. (c) Vedejs, E.; 
Haight, A. R.; Moss, W. O., J. Am. Chem. Soc., 1992, 114, 6556.  
2. (a) Davies, A. G.; Gielen, M.; Pannell, K. H.; Tiekink, E. R. T., Tin Chemistry: 
Fundamentals, Frontiers, and Applications, ed.; John Wiley & Sons Ltd: United 
Kingdom, 2008. (b) Davies, A. G., Organotin Chemistry, ed.; Wiley-VCH Verlag 
GmbH & Co.: Weinheim, 2004. (c) Smith, P. J., Chemistry of Tin, ed.; Blackie 
Academic & Professional: London, 1998. (d) Parr, J., Annu. Rep. Prog. Chem., 
Sect. A: Inorg. Chem. 2009, 105, 117. (e) Harrison, G. P.; Coord. Chem. Rev., 
1985, 66, 190. 
3. (a) Verkade, J. G., Acc. Chem. Res., 1993, 26, 483. (b) Voronkov, M. G.; 
Baryshok, V. P., J. Organomet. Chem. 1982, 239, 199. (c) Verkade, J. G., Coord. 
Chem. Rev. 1994, 137, 233. (d) Tzschach, A.; Ponicke, L.; Korecz, L.; Burger, K., 
J. Organomet. Chem. 1973, 59, 199. 
4. (a) Voronkov, M. G.; Baryshok, V. P., J. Organomet. Chem. 1982, 239, 199. (b) 
Verkade, J. G., Coord. Chem. Rev., 1994, 137, 233. (c) Jurkschat, K.; Tzchach, A. 
J., Organomet. Chem. 1984, 272, C13. (d) Jurkschat, K.; Tzchach, A.; Meunier-
Piret, J., J. Organomet. Chem. 1986, 315, 45. (e) Zoller, T.; Dietz, C.; Berends, L. 
I.; Karsten, O.; Bradtmoller, G.; Wiegand, A-K.; Wang, Y.; Jouikov, V.; 
Jurkschat, K., Inorg. Chem. 2012, 51, 1041. (f) Jurkschat, K.; Mugge, C.; 
Tzschach, A.; Zschunke, A.; Engelhardt, G.; Lippmaa, E.; Magi, M.; Larin, M. F.; 
Pestunovich, V. A.; Voronkov, M. G., J. Organomet. Chem. 1979, 171, 301. (g) 
	 101	
Korecz, L.; Saghier, A. A.; Burger, K.; Tzschach, A.; Jurkschat, K., Inorg. Chim. 
Acta, 1982, 58, 243. (h) Mugge, C.; Pepermans, H.; Gielen, M.; Willem, R.; 
Tzschach, A.; Jurkschat, K.; Anorg. Z., Allg. Chem. 1988, 567, 122. (i) Zoller, T.; 
Jurkschat, K., Inorg. Chem., 2013, 52, 1872.  
5. (a) Napolitano, E.; Farina, V.; Persico, M., Organometallics. 2003, 22, 4030. (b) 
Farina, V., Pure Appl. Chem. 1996, 68, 73.  
6. (a) Brown, J. M.; Pearson, M.; Jastrzebski, J. T. B. H.; van Koten, G., J. Chem. 
Soc. 1992, 19, 1440. (b) Vedejs, E.; Haigt, A. R.; Moss, W. O., J. Am. Chem. Soc. 
1992, 114, 6556. (c) Jensen, M. S.; Yang, C.; Hsiao, Y.; Rivera, N.; Wells, K. M.; 
Chung, J. Y. L.; Yasuda, N.; Hughes, D. L.; Reider, P. J., Org. Lett. 2000, 2, 
1981. (d) Sebahar, H. L.; Yoshida, K.; Hegedus, L. S.,  J. Org. Chem. 2002, 67, 
3788. (e) Shimada, S.; Yamazaki, O.; Tanaka, T.; Rao, M. L. N.; Suzuki, Y.; 
Tanaka, M., Angew. Chem. Int. Ed. 2003, 42, 1845. 
7. Hayashi, T.; Takahashi, M.; Takaya, T.; Ogasawara, M., J. Am. Chem. Soc. 2002, 
124, 5052. 
8. Vedejs, E.; Haigt, A. R.; Moss, W. O.,  J. Am. Chem. Soc. 1992, 114, 6556. 
9. Hicks, J. D.; Hyde, A. M.; Cuezva, A. M.; Buchwald, S. L., J. Am. Chem. Soc. 
2009, 131, 16720. 
10. Tomori, H.; Fox, J. M.; Buchwald, S. L., J. Org. Chem. 2000, 65, 5334. 
11. Kaye, S.; Fox, J. M.; Hicks, F. A.; Buchwald, S. L., Adv. Synth. Catayl. 2001, 
343, 789. 
12. Surry, D. S.; Buchwald, S. L., Chem. Sci. 2011, 2, 27. 
13. (a) Beak, P.; Kerrick, S. T.; Wu, S.; Chu, J., J. Am. Chem. Soc. 1994, 116, 3231. 
	 102	
(b) Beak, P.; Basu, A.; Gallagher, D. J.; Park, Y. S.; Thayumanavan, S., Acc. 
Chem. Res. 1996, 29, 552. 
14. (a) Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M., J. Am. Chem. 
Soc. 2009, 131, 5024. (b) Goli, M.; He, A.; Falck, J. R., Org. Lett. 2011, 13, 344. 
(c) Sandrock, D. L.; Jean-Gerard, L.; Chen, C-Y.; Dreher, S. D.; Molander, G. A., 
J. Am. Chem. Soc. 2010, 132, 17108. (d) Ohmura, T.; Awano, T.; Suginome, M., 
J. Am. Chem. Soc. 2010, 132, 13191. (e) Lee, J. C. H.; McDonald, R.; Hall, D. G., 
Nature Chem., 2011, 3, 894. (f) Molander, G. A.; Wisniewski, S. R., J. Am. 
Chem. Soc. 2012, 134, 16856. 
15. Farina, V.; Krishnamurthy, V.; Scott, W. J., Organic Reactions. 1997, 50, 1.   
16. Liebeskind, L. S.; Fengl, R. W., J. Org. Chem. 1990, 55, 5359.   
17. Farina, V.; Kapadia, S.; Krishnan, B.; Wang, C.; Liebeskind, L. S., J. Org. Chem. 
1994, 59, 5905.   
18. Dragoli, D. R.; Burdett, M. T.; Ellman, J. A., J. Am. Chem. Soc. 2001, 123, 
10127.  
19. Krasovskiy, A.; Knochel, P., Synthesis. 2006, 5, 890. 
20. APEX2 (version 2012.4). Program for Bruker CCD X-ray Diffractometer Con-
trol, Bruker AXS Inc., Madison, WI, 2012. 
21. G. M. Sheldrick, SHELXTL, version 6.14. Program for solution and refinement 
of crystal structures, Universität Göttingen, Germany, 2009. 
22. Vedejs, E.; Haight, A. R.; Moss, W. O., J. Am. Chem. Soc. 1992, 114, 6556. 
23. Campos, K. R.; Klapars, A.; Waldman, J. H.; Dormer, P. G.; Chen, C-Y., J. Am. 
Chem. Soc. 2006, 128, 3538. 
 103 
3] Stereospecific Pd-Catalyzed Acylation of Alkylcarba-
stannatrane Reagents:  A General Alternative to Asymmetric 
Enolate Reactions 
	
3.1] Introduction 
Synthetic approaches to the formation of ketones, especially those with other 
functional groups and stereogenic centers, are of great interest due to their presence in a 
wide variety of valuable chemicals and drugs.1 The use of carboxylic acid derivatives as 
the starting material is a versatile and widely accepted approach to ketone synthesis. For 
the preparation of α-stereogenic ketones, catalyst-controlled and auxiliary-controlled 
asymmetric enolate reactions have been broadly employed. These approaches have been 
extensively applied to the construction of complex organic molecules (Figure 1a).1 
 
Figure 1. Retrosynthetic approaches to the asymmetric construction of a-substituted carbonyl com-
pounds. 
 Ketones that have at least one α-hydrogen can undergo keto-enol tautomerization 
to form an enol tautomer. This equilibrium allows ketones to be prepared via enolates. 
R1
O
R2
E
R1
O
R3
R2
R1 X
O R3
R2
M
R1
OM
R2
(a) Catalyst- or auxiliary-                  
    controlled asymmetric 
     induction:
(b) Reagent-controlled     
     enantiospecificity:
E+
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When keto-enol tautomerism occurs, the keto or enol is deprotonated to form an anion, 
which is called the enolate. However, the development of a general approach to employ 
enolates and enolate equivalents in asymmetric reactions has been hindered by multiple 
complicating factors. First, a catalyst or auxiliary must broadly control facial attack on 
the enolate independent of the enolate carbon skeleton or the functional groups present. 
Second, reaction conditions must not be conducive to racemization of the newly formed 
stereogenic center, which is particularly challenging in arylation reactions. 2 Third, when 
ketones possess two enolizable carbon atoms, the chemoselectivity of the enolization 
process must be efficiently controlled. In principle, a stereospecific coupling reaction 
between a stable, optically active organometallic nucleophile and an acyl electrophile 
(Figure 1b) would circumvent these constraints. Because such cross-coupling reactions 
would feature completely reagent-controlled enantiospecificity, the transfer of stereo-
chemical information should be both general and predictable. However, one transfor-
mation that remains underdeveloped is the transition-metal-catalyzed cross-coupling 
reaction between carboxylic acid derivatives and C(sp3) organometallic reagents to 
prepare ketones. The reaction of acid halides and organometallic compounds (i.e., Zn, 
Cd, Mg) has been historically used for ketone synthesis. Although organozinc com-
pounds were generally employed prior to the 1930s, organocadmium reagents were 
subsequently demonstrated to be more satisfactory. 3 To date, transition metal catalysis	
has been applied widely in the synthesis of a variety of ketones constituting aryl-aryl, 
alkyl-aryl, and alkyl-alkyl groups. However, the scarcity of sec-alkyl organometallic 
reagent couplings with acyl derivatives is indicative of the inherent difficulties of transi-
tion metal catalyzed reactions involving C(sp3)-hybridized coupling partners.  Therefore, 
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the reaction of carboxylic acid halides and organometallic compounds has been restrict-
edly to diaryl ketone synthesis. Recently, several transition-metal-catalyzed cross-
coupling reactions of acid chlorides and alkyl organometallic reagents to form ketones 
have been reported.4-15 In 1998, Fukuyama and co-workers reported the Pd-catalyzed 
coupling of thioesters and primary alkyl organozinc or hydride reagents, generating 
ketone or aldehyde products, respectively (Figure 2c).4 The advantages of the reactions 
are high chemoselectivity, mild reaction conditions and the use of less-toxic reagents. In 
addition, the protocol is compatible with functional groups such as ketones, acetates, 
sulfides, aromatic bromides, chlorides and aldehydes. 
A number of functional groups are tolerated due to the relative stability of both 
coupling components. Seki and collegues5 have since developed both heterogeneous and 
phosphine-free Pd-catalyzed Fukuyama couplings, as well as a Ni-catalyzed Fukuyama 
coupling. Despite these advances, the use of secondary C(sp3) organometallic reagents 
still remains challenging. While α,α-disubstituted ketones can be prepared by direct 
attack of a variety of strongly nucleophilic organometallic species onto acyl electrophiles, 
such protocols are frequently accompanied by over-addition products due to the electro-
philicity of the newly formed ketone.6 Specialized acyl derivatives, such as Weinreb 
amides, can minimize over-addition; however, these electrophiles require the use of 
organolithium or Grignard reagents, which suffer from poor functional group tolerance.7 
Recent strategies to eliminate the need for alkyl organometallic reagents in ketone syn-
thesis include reverse-polarity cross-couplings8 and reductive cross-couplings. 9 Although 
substantial progress has been made on the transition-metal-catalyzed cross-coupling 
reactions between acyl electrophiles and primary alkyl organometallic reagents, there are 
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few reports describing the coupling of secondary alkyl organometallics. In an early study, 
Harada and Oku10 disclosed the coupling of secondary organozinc reagents with acid 
chlorides and obtained moderate yields of ketone product (Figure 2a), although the 
functional group tolerance of the reaction was not further explored. Zhang and Wang 
reported a high-yielding reaction between iPrZnI and the mixed anhydride generated 
from sodium benzoate (Figure 2e); however the additional substrate scope was not dis-
closed.11 Subsequently, Mori and Seki reported a Pd-catalyzed coupling of iPr2Zn that 
proceeds (Figure 2f).12 Rovis and Zhang have also reported a single case of a high-
yielding coupling between an acid fluoride and iPr2Zn (Figure 2g).
13 Also, Liebeskinde-
Srogl coupling of thioesters and organoboron nucleophiles proceeds only with primary 
organoboron reagents despite efforts to extend the reaction to secondary reagents (Figure 
2d).14 Finally, Reisman reported a general method for the cross-coupling of secondary 
organozinc reagents and thioesters as well as a mild, chemoselective Ni-catalyzed asym-
metric reductive acyl cross-coupling reaction which provides access to a variety of α-
aryl-α-alkyl ketones in good yields and moderate enantioselectivity (Figure 2h). This 
reaction is highly convergent and functional group tolerant, which enables the rapid 
construction of complex ketones from bench stable, easy-to-handle starting materials.15 
Based upon Reisman’s result, Maulide reported the first enantioconvergent palladium-
catalyzed Fukuyama cross-coupling of racemic benzylic organozinc reagents with thioe-
sters (Figure 2i). The reaction furnishes enantioenriched acyclic α-disubstituted ketone 
products under mild reaction conditions without racemization of the potentially labile 
tertiary stereocenters to provide high enantioselectivities.16  
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Figure	2.	Acyl cross-coupling reactions with secondary organometallic reagents. 4-15	
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Although the first stereospecific Pd-catalyzed reaction of acid chlorides with en-
antiomerically enriched α-(benzoyloxy)-stannanes was reported over twenty years ago by 
Falck group (Figure 2b),17 the Pd-catalyzed cross-coupling reaction between acyl electro-
philes and organotin reagents is still relatively unexplored. We therefore decided to 
investigate the efficiency of palladium-catalyzed reactions of acyl electrophiles and 
alkylcarbastannatranes. Based upon our successful use of enantioenriched alkyl carbas-
tannatranes in stereospecific arylation reactions, we felt that enantioenriched alkyl-
carbatannatranes might be similarly applied to stereospecific acylation reactions.		
	
3.2] Reaction Optimization 
In our initial exploratory studies, we used the Pd-catalyzed coupling of benzoyl 
chloride and i-propylcarbastannatrane (1) as a model system, and the best conditions of 
arylation reactions were implemented directly in the acylation reactions. We found that 
the yield of desired cross-coupling product (2) was only 21% GC yield in the presence of 
the KF due to the background formation of benzoyl fluoride.   Hence, removal of KF 
solved the byproduct issue easily and the desired product (2) could be generated in 78% 
GC yield using 5 mol % Pd(dba)2 with 10 mol % Jackiephos alongside two equivalents of 
CuCl in acetonitrile at 60 ºC (Entry 1, Figure 3a). 
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Figure 3a. Initial optimization of the Pd-Catalyzed Cross-Coupling Reaction of Benzoyl Chloride and i-
propylcarbastannatrane (1). Yields and selectivities determined by GC analysis. 
 
No byproducts of isomerization of the secondary alkyl component from β-hydride 
elimination/reinsertion were observed in these reactions. When i-Pr4Sn was used in place 
of carbastannatrane 1, no product 2 was formed. This highlights the unique ability of the 
carbastannatrane backbone to selectively labilize bulky, inactivated alkyl groups that are 
typically inert towards transmetallation. With the objective of expanding the synthetic 
utility of acyl Pd-catalyzed cross-coupling reactions, different phosphine ligands were 
screened using carbastannatrane 1. Reactions were performed on 0.02 mmol scale using 
				Entry	 								Pd		 							Ligand	 		CuCl		 				Solvent	 				Temp.	 					GC	yield	
									1	 					Pd(dba)2	 		Jackiephos	 		CuCl	 					MeCN	 								60	 								78%	
									2	 					Pd(dba)2	 		Jackiephos	 						-	 					MeCN	 								60	 								15%	
									3	 				Pd(PPh3)4	 										-	 		CuCl	 					MeCN	 								60	 								65%	
									4	 				Pd(PPh3)4	 										-	 						-	 					MeCN	 								60	 								<5%	
									5	 		precatalyst	 										-	 		CuCl	 					MeCN	 								60	 								64%	
									6	 		precatalyst	 		Jackiephos	 		CuCl	 					MeCN	 								60	 								81%	
									7		 				Pd(PPh3)4	 										-	 		CuCl	 							THF	 								60	 								65%	
									8	 				Pd(PPh3)4	 										-	 		CuCl	 						DCM	 								60	 								67%	
									9	 				Pd(PPh3)4	 										-	 		CuCl	 			Toluene	 								60	 								61%	
								10	 				Pd(PPh3)4	 										-	 		CuCl	 	2-Me-THF	 								60	 								57%			
								11	 				Pd(PPh3)4	 										-	 		CuCl	 1,4-Dioxane	 								60	 								61%	
Cl
O
+ SnN
CH3
CH3
Pd (5 mol %)
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2 equiv. CuCl
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O
CH3
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1.1 equiv.
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P
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Me
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1 2
Cl
O
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CH3
Pd (5 mol %)
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2 equiv. CuCl, 2 equiv. KF
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O
CH3
CH3
1.1 equiv.
1 2
 111 
different palladium complexes (5 mol %) in 1 mL acetonitrile or other solvents (Figure 
3a).  The reactions were done under argon atmosphere and were stirred at 60 ºC. Ligand 
(10 mol %) screenings were monitored by gas chromatography and the yield of the 
desired product (2) was calibrated using tetradecane as the internal standard.	 After 
screening different combinations of Pd sources and phosphine ligands, we found that 
Pd(PPh3)4 (5 mol %) in the absence of additional ligand provided yields similar to the 
reaction containing a Pd source charged with Jackiephos (Entry 1 and 3, Figure 3a). 
Though Pd(dba)2 with JackiePhos produced the highest yields, the slight difference in 
yield did not justify use of the more expensive JackiePhos ligand. Pd(PPh3)4 (2 mol %) 
with 2 equivalents of CuCl in the absence of additional ligand was found to be the opti-
mal conditions under which reactions should be conducted (Entry 1, Figure 3b). The use 
of CuCl as a co-transmetallating reagent is essential to the success of this reaction (Entry 
2, Figure 3a).18   Therefore, these reactions were also screened in the presence of different 
Cu (I) salts (Figure 3b). 
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Figure 3b. Screening two equivalents of different Cu (I) salts (Yields and selectivities determined by GC 
analysis). 
 
 
  Using the optimized conditions, the scope of the reactions was examined using 
different electrophiles and nucleophiles on a larger scale (0.3 mmol) (Figure 4). We 
found that acyl chlorides bearing heteroaryl groups could be efficiently employed as 
electrophiles. Inclusion of an ortho-methyl substituent on benzoyl chloride had little 
impact on the reaction. Acyl chlorides bearing alkyl groups underwent coupling (9 and 
10, Figure 4) without evidence of alkyl isomerization via decarbonylation/β-hydride 
Entry	 	Pd(PPh3)4	 				CuCl	 											CuX		 Temp.	 GC	Yield	 Time	
1	 2	mole	%	 2.0	equiv.	 																	-	 60	oC	 72%	 6	hr	
2	 5	mole	%	 2.0	equiv.	 																	-	 60	oC	 74%	 6	hr	
3	 10	mole	%	 2.0	equiv.	 																	-	 60	oC	 75%	 6	hr	
4	 2	mole	%	 0.5	equiv.	 																	-	 60	oC	 49%	 6	hr	
5	 2	mole	%	 4.0	equiv.	 																	-	 60	oC	 85%	 6	hr	
6	 2	mole	%	 2.0	equiv.	 																	-	 RT	 72%	 12	hr	
7	 2	mole	%	 2.0	equiv.	 																	-	 60	oC	 79%	 12	hr	
8	 2	mole	%	 2.0	equiv.	 																	-	 85	oC	 80%	 12	hr	
9	 2	mole	%	 							-	 CuBr,	CuI,	CuCl	 60	oC	 69-79%	 12	hr	
10	 2	mole	%	 							-			 CuSal,	CuTc	 60	oC	 25-29%	 12	hr	
11	 2	mole	%	 							-	 Cu(I)	(-OAc,	-CN,	-SCN)	 60	oC	 <20%	 12	hr	
Cl
O
+ SnN
CH3
CH3
Pd(PPh3)4 (2~10 mol %)
0.5~4 equiv. Cu(I)
CH3CN, RT~85 ºC, 6~12hrs
O
CH3
CH3
1.1 equiv.
1 2
CH3
OH
OCu
O
CuSal = Copper(i) 3-methylsalicylate
S O
OCu
CuTc = Copper(i) thiophene-2-carboxylate
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elimination/reinsertion/re-carbonylation sequences.19 Chloro-substituted arenes were also 
well tolerated under these reaction conditions, which should enable cross-coupling prod-
ucts such as 4 and 5 to be further modified using existing cross-coupling technologies. In 
regards to the nucleophilic component, use of unactivated primary and unactivated 
secondary alkylcarbastannatranes was tolerated under the standard reaction conditions. 
No isomerization of the secondary alkyl nucleophiles was observed in these reactions. In 
addition to revealing the optimal reaction conditions, the results from the screens indicate 
the potential of using Pd(dba)2 and JackiePhos for particularly unactivated substrates. 
Because of the special features of JackiePhos to facilitate the transmetallation and reduc-
tive elimination, it is reasonable to expect the better results from Pd(dba)2/JackiePhos 
than Pd(PPh3)4. For example, the synthesis of compounds 15a and 15b using t-
butylcarbastannatrane required the use of JackiePhos of the ligand. These examples 
constitute the first instances of t-butyl transfer from an alkylstannane in a cross-coupling 
reaction. With Pd(PPh3)4 (5 mol %), we observed significant isomerization of t-butyl to i-
butyl. The use of bulky biarylphosphine ligand JackiePhos completely suppressed isom-
erization	and increased the yields.  
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Figure 4. Pd-Catalyzed Cross-Coupling Reactions of Alkylcarbastannatranes and Acyl Chlorides 
 
3.3] Cross couplings of enantioenriched alkylcarbastannatranes  
Enantioenriched acyclic α,α’-disubstituted carbonyl compounds are versatile syn-
thetic intermediates for the synthesis of natural products and pharmaceutical chemicals. 
Due to their ubiquity and utility, the development of new synthetic methods to prepare 
such compounds has been the subject of intense research. Recently, the Reisman group 
has generated acyclic α,α-disubstituted ketones in good yields and with high enantiose-
lectivity via a Ni-catalyzed asymmetric reductive cross-coupling reaction of acid chlo-
rides and racemic secondary benzyl chlorides using a NiII/ (R,R)-diphenyl-BOX catalyst 
in the presence of Mn0
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of the Pd-catalyzed cross-coupling reactions of unactivated enantioenriched tin nucleo-
philes with acyl electrophiles has been previously reported.  
 
 
Figure 5. Catalytic Asymmetric Reductive Acyl Cross-Coupling reactions by the 
Reisman group. 
 
We explored the use of enantioenriched alkylcarbstannatrane in Pd-catalyzed 
cross-coupling reactions with acyl chlorides. Using these nucleophiles, secondary alkyl 
groups underwent transmetallation to palladium with excellent retention of configuration 
when an optically active secondary alkyl carbastannatrane was employed. While we 
initially disclosed the use of optically active alkylcarbastannatrane reagents (16) in 
stereospecific arylation reactions, enantioenrichment of optically active alkylcarbas-
tannatrane reagents was achieved only via asymmetric lithiation/stannylation or via 
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carbastannatrane21 and enantioenriched secondary alkyl mesylates (Figure 6). This reac-
tion should significantly expand the accessibility of inactivated, enantioenriched alkyl-
carbastannatranes for potential use in stereospecific reactions. Herein we implemented 
the unactivated, enantioenriched alkyl carbastannatranes coupled with acyl electrophiles. 
The substrates scope is shown in Figure 6.  
 
 
Figure 6.	 Stereospecific Pd-catalyzed couplings of enantioenriched alkylcarbastannatranes and acyl 
chlorides.  
When unactivated, enantioenriched, secondary alkylcarbastannatranes 16a and 
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with our arylation reactions in second chapter23,  this process proceeds with net retention 
of absolute configuration. In seminal studies conducted by Falck and others, stereospecif-
ic couplings of enantioenriched alkytin nucleophiles and acid chlorides were limited to 
use of specific classes of activated alkyltin nucleophiles.24 To evaluate stereoelectronic 
influences of the nucleophile on stereospecificity in the present system, we also studied 
the use of electronically activated enantioenriched carbastannatranes (16c and 16d) in 
these cross-coupling reactions. 16c and 16d both underwent cross-coupling reactions 
with exceptionally high stereofidelity. Therefore, electronic perturbations of the C(sp2) α-
carbon or strongly coordinating β-carbonyl nucleophiles do not appear to influence 
stereospecificity in this process. Retrosynthetically, products 17-24 constitute formal 
asymmetric alkylation reactions of enolates, whereas 25 and 26 constitute formal asym-
metric arylation reactions of enolates. It is noteworthy that the mild conditions employed 
in this process are not conducive to racemization of the enantioenriched product, even 
with an α-aryl substituent present. The combined results of Figures 4 and 6 suggest that 
the nucleophilic scope of this reaction is quite broad. Primary, secondary, and tertiary 
alkylcarbastannatranes may be successfully employed in acylation reactions. Activated 
and inactivated secondary alkylcarbastannatranes all undergo highly efficient stereospe-
cific cross-coupling reactions using identical conditions. Oxygen-containing nucleophiles 
could also be readily employed. Unfortunately, carbastannatranes bearing nitrogen-
containing groups (e.g., piperidine and pyrrolidine derivatives) were largely unsuccessful 
in these reactions. This appears to be the major limitation of the present system.  
As previously mentioned, thioesters are more stable and more easily handled than 
their corresponding acid chlorides. Inspired by Falck and Liebeskind’s research on 
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copper(I) mediated thioester-organostannane cross-coupling reactions,25 we investigated 
the use of thioesters as acyl electrophiles in stereospecific cross-coupling reactions.26 
Using the standard conditions with 2 mol % Pd(PPh3)4 alongside 2 equivalents of CuCl, 
or with stoichiometric CuTc (Copper(I) thiophene-2-carboxylate) in the absence of 
palladium, we successfully performed the cross-coupling reactions of para-substituted S-
phenyl benzothioates with alkylcarbastannatranes. Reactions using CuTc resulted in 
acceptable yields of cross-coupling products (Figure 7a). Using both conditions, we 
conducted cross-coupling reactions of (S)-16b and thioester 27. Each reaction resulted in 
relatively high yield and respectable stereofidelity (Figure 8). Therefore, enantioenriched 
products from cross-coupling reactions involving a thioester and stoichiometric CuTc 
(without palladium) could still be generated in reasonable yields (Figure 7b).  Since non-
racemic thioesters can be readily prepared from enantioenriched a-chiral carboxylic 
acids, we felt that such thioesters might be effective substrates for diastereospecific 
reactions, forming optically active a,a’-disubstituted ketones with complete reagent 
control of stereochemistry. Using the thioester of (S)-Naproxen (28), we successfully 
generated syn-29 and anti-29 from stereospecific reactions with (R)-16a and (S)-16a, 
respectively. The products of these reactions completely retained the stereochemistry of 
their original coupling partners (Figure 8). 
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Figure 7a. Cross-coupling reactions of alkyl carbastannatranes and thioesters. a. Yields determined by 
GC analysis. b. Average isolation yields in two runs. 
Figure 7b. Screening of alkyl carbastannatranes and thioesters. a. Yields determined by GC analysis.  
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Figure 8. Stereospecific cross-coupling reactions of enantioenriched carbastannatranes and thioesters. 
 
3.4] Conclusion 
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entirely reagent controlled, this process constitutes an alternative, predictable synthetic 
route to asymmetric enolates. These reactions occur with outstanding stereofidelity and 
with retention of the absolute configuration. We have additionally shown that the carba-
stannatrane backbone facilitates the transfer of t-butyl groups in Pd-catalyzed cross-
coupling reactions.  This represents the first example of the selective transfer of an inacti-
vated tertiary alkyl group from tin (15a and 15b) and suggests that the stereospecific 
formation of quaternary centers may be possible from enantioenriched tertiary alkylcar-
bastannatranes. 
 
3.5] Experimental data 
General Reagent Information 
	
BDH brand ethyl ether was purchased from VWR.  EMD brand Omnisolv THF (unstabi-
lized) was also purchased from VWR.  These solvents were transferred to separate 20 L 
solvent-delivery kegs and vigorously purged with argon for 2 h. The solvents were 
further purified by passing them under argon pressure through two packed columns of 
neutral alumina. s-BuLi (1.4 M in cyclohexane) and isopropylmagnesium chloride (2.0 M 
in ether) were purchased from SigmaAldrich. 5-Chloro-1-aza-5-
stannabicyclo[3.3.3]undecane was purchased from SigmaAldrich or prepared via the 
method of Vedejs.27 Pd(PPh3)4 was purchased from Strem. Anhydrous acetonitrile (Sig-
ma-Aldrich) was purged with argon prior to use.  Grignard reagents were prepared from 
their corresponding alkyl chlorides or bromides using a literature procedure.28 Thioesters 
were prepared from their corresponding carboxylic acids or acyl chlorides using a litera-
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ture procedure.29 Molarities of Grignard reagents were determined using iodine titra-
tion.30 Reagents and solvents were used as received unless otherwise noted.  Flash chro-
matography was performed using Silicycle silica gel (ultra pure grade).  Reverse-phase 
chromatography was performed using C18 silica gel from Silicycle (17% carbon, 40-63 
mm) or from Acros (23% carbon, 40-63 mm). 
	
General Analytical Information  
	
All compounds were characterized by 1H NMR and 13C NMR spectroscopy. Copies of 
the 1H and 13C spectra for all new compounds can be found at the end of the Supporting 
Information.  All previously unreported compounds were additionally characterized by 
high resolution MS. Nuclear Magnetic Resonance spectra were recorded on a Bruker 300 
or Varian 500 MHz instrument.  All 1H NMR experiments are reported in δ units, parts 
per million (ppm), and were measured relative to the signals for residual chloroform 
(7.26 ppm).  All 13C NMR spectra are reported in ppm relative to deuterochloroform 
(77.23 ppm), and were obtained with 1H decoupling. High resolution MS analyses were 
performed on an Agilent 6520 Q-TOF instrument.  All GC analyses were performed on a 
Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m x 0.20 mm 
capillary column with cross-linked methyl siloxane as the stationary phase, or using a 30 
m x 0.32 mm chiral column (Rt®-βDEXsm from Restek).  All GC yields were calibrated 
using dodecane or tetradecane as an internal standard. Chiral HPLC analyses were per-
formed on a Shimadzu Prominence HPLC system with binary mobile phase pumps and 
UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (4.6 mm x 150 mm; particle size: 
5 µm) chiral column (Daicel Chemical Ind., Ltd), an IA-3 (4.6 mm x 150 mm; particle 
size: 3 µm) chiral column (Daicel Chemical Ind., Ltd), or an IA (4.6 mm x 150 mm; 
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particle size: 5 µm) chiral column (Daicel Chemical Ind., Ltd).  VCD analysis was per-
formed by BioTools, Inc (Jupiter, Fl).  Preparative HPLC separations were performed by 
Chiral Technologies, Inc.  Thin layer chromatography was performed using EMD milli-
pore normal phase silica-coated glass plates (F254, #105715), or using EMD millipore 
reverse phase silica-coated glass plates (F254-S, #105560). 
	
 
 
Procedural Information 
 
General procedure A  for the preparation of racemic secondary alkylcarbastannatranes. 
	
All reactions were performed in oven-dried glassware under an atmosphere of Ar.  sec-
Alkyllithium, sec-alkylmagnesium or sec-alkylzinc reagents (1.5–3.0 equiv) were added 
to the suspension of 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane26 (1 equiv) in anhy-
drous solvent at -78 °C. The resulting mixture was stirred at -78 °C for 3 h, allowed to 
warm to room temperature, and stirred overnight.  The reaction mixture was poured into a 
separatory funnel containing a mixture of water and ether. The organic layer was separat-
ed, washed with brine, dried over Na2SO4, and filtered. Solvent was removed under 
reduced pressure and dried in vacuo to provide the crude product.  The crude secondary 
alkyl tin reagents were used without purification, or following purification via Kugelrohr 
distillation or C18 chromatography. Homocoupling from Grignard formation constituted 
the major residual byproduct in the crude product. 
	
General procedure B  for cross-coupling reactions.  
	
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-
dried test tube with stir bar. With stirring begun, the septum screw top tube was evacuat-
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ed (80 mTorr) and backfilled three times with argon using a needle attached to a vacuum 
manifold. The tin reagent (1.1 equiv) and acyl chloride (1 equiv) were then added to the 
test tube via microsyringe, followed by degassed CH3CN (1 mL for 0.3 mmol scale). If 
the acyl chloride was a solid, it was weighed out on the benchtop alongside the other 
solids. The tube was sealed using electrical tape, and heated to 60 °C for 12 h. The reac-
tion mixture was cooled to rt, diluted with ether, and washed with brine.  The organic 
layer was dried over Na2SO4, filtered, and concentrated to provide the crude product. The 
crude product was purified by column chromatography. 
	
General procedure C  for cross-coupling reactions with heterocyclic acyl chlorides. 
	
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-
dried Schlenk tube with stir bar. With stirring begun, the Schlenk tube was evacuated (80 
mTorr) and backfilled three times with argon using a needle attached to a vacuum mani-
fold. The tin reagent (1.1 equiv) and acyl chloride (1 equiv) was then added to the 
Schlenk tube via microsyringe, followed by degassed CH3CN (1 mL for 0.3 mmol scale). 
If the acyl chloride was a solid, it was weighed out on the benchtop alongside the other 
solids. The Schlenk tube was sealed with a Teflon stopper, and heated to 60 °C for 12 h. 
The reaction mixture was cooled to rt, diluted with ether, and washed with brine.  The 
organic layer was dried over Na2SO4, filtered, and concentrated to provide the crude 
product. The crude product was purified by column chromatography. 
	
General procedure D  for cross-coupling reactions with t-butyl carbastannatrane. 
	
Pd(dba)2 (5 mol %), Jackiephos (10 mol %), CuCl (2 equiv), and t-butyl carbastannatrane 
(1.1 equiv) were weighed out on the benchtop into an oven-dried Schlenk tube with stir 
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bar. With stirring begun, the Schlenk tube was evacuated (80 mTorr) and backfilled three 
times with argon using a needle attached to a vacuum manifold. The acyl chloride (1 
equiv) was then added to the Schlenk tube via microsyringe, followed by degassed 
CH3CN (1 mL for 0.3 mmol scale). If the acyl chloride was a solid, it was weighed out on 
the benchtop alongside the other solids. The Schlenk tube was sealed with a Teflon 
stopper, and heated to 60 °C for 12 h. The reaction mixture was cooled to rt, diluted with 
ether, and washed with brine.  The organic layer was dried over Na2SO4, filtered, and 
concentrated to provide the crude product. The crude product was purified by column 
chromatography. 
	
General procedure E for cross-coupling reactions with thioesters. 
	
Pd(PPh3)4 (2-5 mol %), CuCl (2 equiv), and thioester (1 equiv) were weighed out on the 
benchtop into an oven-dried Schlenk tube with stir bar. With stirring begun, the Schlenk 
tube was evacuated (80 mTorr) and backfilled three times with argon using a needle 
attached to a vacuum manifold. The tin reagent (1.1 equiv) was then added to the Schlenk 
tube via microsyringe, followed by degassed CH3CN (1 mL for 0.2 or 0.3 mmol scale). 
The Schlenk tube was sealed with a Teflon stopper, and heated to 60 °C for 12 h. The 
reaction mixture was cooled to rt, diluted with ethyl acetate, and washed with brine.  The 
organic layer was dried over Na2SO4, filtered, and concentrated to provide the crude 
product. The crude product was purified by column chromatography. 
	
General procedure F for the preparation of optically active secondary alkylcarbas-
tannatranes.32 
	
To an oven dried round bottom flask with stirbar, 5-chloro-1-aza-5-stanna-
bicyclo[3.3.3]undecane (588 mg, 2 mmol)  and naphthalene (128 mg, 1 mmol) were 
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added.  The flask was evacuated (<100 mtorr) and backfilled with argon three times.  
With the flask under a flow of argon, the septum was removed and lithium granules (free 
of oil) were added (250 mg, 35 mmol). This was followed by two additional evacua-
tion/backfill cycles. Anhydrous THF (40 mL) was added to the flask via syringe, and the 
mixture was stirred at room temperature. The solution turned dark green/black within 30 
min.  Upon color change, the solution was stirred at room temperature for an additional 
hour.  In a separate 100 mL flask under argon, with stirbar and rubber septum, the opti-
cally active alkyl mesylate (1.2–1.5 equiv) was dissolved in anhydrous THF (20 mL).  
The mesylate solution was heated to 60 °C.  The stannatrane lithium mixture was re-
moved from the excess lithium via cannula or needle/syringe, and transferred dropwise to 
the mesylate solution over 5 mins. The reaction stirred at 60 °C for an additional hour. 
The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 
mL), and dried over Na2SO4. The reaction solution was filtered and concentrated to 
provide the crude product. The crude product was purified (40–50% isolated yield) by 
C18 silica (80/20 acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC 
(220/254 nm) or reverse-phase TLC.  
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Additional optimization experiments 
 
 
 
 
 
N-Heterocyclic carbastannatranes that failed in cross-coupling reactions 
 
 
 
 
 
 
Compound Characterization 
	
	
	 	
	
5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane.31 General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2.94 g, 10.0 mmol) in 
ether (40 mL) and s-BuLi (1.4 M in cyclohexane, 15 mL, 21 mmol). A yellow oil (3.18 g, 
99%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.64 (app. 
quint, J = 6 Hz, 6H), 1.41-1.51 (m, 3H), 1.05 (d, J = 7.5 Hz, 3H), 0.86 (t, J = 7 Hz, 3H), 
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0.63 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 55.0, 29.4, 26.7, 23.7, 18.5, 
14.8, 5.7 ppm.  
 
(R)- and (S)-5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general proce-
dure F was employed using  (S)-(sec-butyl) mesylate or  (R)-(sec-butyl) mesylate (430 
µL, 3 mmol). A pale yellow oil (40–50%) was isolated.  Enantiomeric excess of product 
ranged from 91–99% ee (determined by derivatization with 4-bromoanisole or 4-
bromobenzotrifluoride – see page 21 of SI).6,7  
	
	
	
	
5-(iso-Propyl)-1-aza-5-stannabicyclo[3.3.3]undecane.32 General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.47 g, 5.0 mmol) in 
ether (20 mL) and isopropylmagnesium chloride (2.0 M in ether, 7.5 mL, 15 mmol). A 
yellow oil (1.41 g, 95%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.38 (t, J = 6 Hz, 
6H), 1.67 (app. quint, J = 6 Hz, 6H), 1.09 (d, J = 7.5 Hz, 6H), 0.70-0.76 (m, 1H), 0.65 (t, 
J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 54.9, 23.6, 21.6, 17.7, 4.6 ppm.  
	
	
	
	
5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.32 General 
procedure A was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 
3.0 mmol) in THF (30 mL) and (tetrahydro-2H-pyran-4-yl)magnesium chloride (0.62 M 
SnN
CH3
CH3
SnN O
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in THF, 7 mL, 4.3 mmol). A pale yellow solid (983 mg, 95%) was isolated. 1H NMR 
(500 MHz, CDCl3) δ: 3.87 (m, 2H), 3.33 (dt, J = 11, 2 Hz, 2H), 2.36 (t, J = 6 Hz, 6H), 
1.64 (app. quint, J = 6 Hz, 6H), 1.50-1.55 (m, 4H), 0.89-0.95 (m, 1H), 0.64 (t, J = 6.5 Hz, 
6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 71.0, 54.8, 31.3, 26.0, 23.4, 4.6 ppm.  
	
	
	
5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.32 General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.65 g, 5.6 mmol) 
in THF (50 mL) and (4-phenylbutan-2-yl)magnesium chloride (0.28 M in THF, 23 mL, 
6.4 mmol).  A pale yellow oil (1.74 g, 79%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 
7.25-7.28 (m, 2H), 7.16-7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t, J = 6 Hz, 6H), 1.76-
1.81 (m, 1H), 1.65 (app. quint, J = 6 Hz, 6H), 1.23-1.39 (m, 1H), 1.13 (d, J = 7.5 Hz, 
3H), 0.79 (quart, J = 7.5 Hz, 1H), 0.67 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, 
CDCl3) δ: 143.9, 128.6, 128.3, 125.5, 54.9, 39.0, 36.5, 24.2, 23.6, 18.6, 5.6 ppm.  
 
(S)-5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (16b). General 
procedure F was employed using (R)-(4-phenylbutan-2-yl)mesylate (500 µL, 2.4 mmol). 
A pale yellow oil (320 mg, 40%) was isolated. Enantiomeric excess of product ranged 
from 91–99% ee between different runs.  Enantiomers could also be separated on a 
preparative scale using a Chiralpak OJ-H column with a 95:5 methanol:water eluent. 
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Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (16c).32  General proce-
dure A was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 
mmol) in DMF (8 mL) and (4-ethoxy-4-oxobutan-2-yl)zinc iodide (0.61 M in DMF, 10 
mL, 6.1 mmol). An orange oil (509 mg, 45%) was isolated. 1H NMR (500 MHz, CDCl3) 
δ: 4.09 (quart, J = 7 Hz, 2H), 2.39-2.43 (m, 1H), 2.35 (t, J = 6 Hz, 6H), 2.23-2.27 (m, 
1H), 1.64 (app. quint, J = 6 Hz, 6H), 1.24 (t, J = 7 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J 
= 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 
18.4, 14.6, 5.2 ppm. Enantiomers were separated on a preparative scale using a Chiralpak 
OJ-H column with a 100:0.1 hexane:IPA eluent. 
	
	
	
	
5-(3-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (294 mg, 1 mmol) in 
THF (5 mL) and 3-phenylpropylmagnesium chloride (0.31 M in THF, 10 mL, 3.1 mmol). 
A yellow oil (189 mg, 50%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 
5H), 2.53 (t, J = 7.5 Hz, 2H), 2.36 (t, J = 6.2 Hz, 6H), 1.69 (quint, J = 6 Hz, 2H), 1.62 
(app. quint, J = 6 Hz, 6H), 0.64 (t, J = 6 Hz, 6H), 0.48 (t, J = 6.0 Hz, 2H) ppm. 13C NMR 
(125 MHz, CDCl3) δ: 143.6, 128.7, 128.3, 125.5, 54.9, 41.5, 29.9, 23.6, 16.4, 6.8 ppm. 
HRMS (ES+): Calcd (116Sn) (M-Na)+ 394.1246; Found (116Sn) 394.1251. 
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5-(1-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (16d). General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (206 mg, 0.7 mmol)  
in THF (5 mL), and 1-phenylethyl magnesium chloride (0.21 M in THF, 10 mL, 2.1 
mmol). A pale yellow oil (100 mg, 38%) was isolated and stored under argon.   1H NMR 
(500 MHz, CDCl3) δ: 7.17-6.87 (m, 5H), 2.32 (t, J = 6 Hz, 6H), 2.03-1.70 (m, 3H), 1.61 
(app. quint, J = 6 Hz, 6H), 0.92 (t, J = 7.5 Hz, 3H), 0.61 (t, J = 6 Hz, 6H) ppm. 13C NMR 
(125 MHz, CDCl3) δ: 149.8, 128.0, 125.8, 121.8, 54.8, 43.0, 25.0, 23.6, 15.5, 5.9 ppm. 
HRMS (ES+): Calcd (116Sn) (M-Na)+ 402.1220; Found (116Sn) 402.1226. Enantiomers 
were separated on a preparative scale using a Chiralcel OJ-H column with a 95:5 metha-
nol:water eluent.  
	
	
	
	
5-(tert-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was em-
ployed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (588 mg, 2.0 mmol) in THF 
(20 mL) and t-butyl lithium (1.4 M in ether, 4.3 mL, 6 mmol). A pale yellow solid (0.35 
g, 56%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.65 (app. 
quint, J = 6 Hz, 6H), 0.92 (s, 9H), 0.63 (t, J = 6 Hz, 6H) ppm. 13C NMR (125 MHz, 
CDCl3) δ: 54.8, 30.3, 23.7, 4.2 ppm.  
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1-(Furan-2-yl)-4-phenylbutan-1-one (3).  General procedure C was employed using 2-
furoyl chloride (39 mg, 0.3 mmol) and 5-(3-phenylpropyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol).  A yellow liquid (86 mg, 89%) was 
isolated by column chromatography (90:10 pentane/MTBE). 1H NMR (300 MHz, 
CDCl3): δ 7.57-7.56 (dd, J = 1.8, 3 Hz, 1H), 7.29-7.13 (m, 6H), 6.52-6.51 (dd, J = 1.8, 3 
Hz, 1H), 2.84 (t, J = 7.5 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H), 2.06 (q, J = 7.5 Hz, 2H) ppm. 
13C NMR (125 MHz, CDCl3): δ 189.6, 153.0, 146.4, 141.8, 128.7, 128.6, 126.2, 117.1, 
112.3, 37.9, 35.4, 25.9 ppm. HRMS (ES+): Calcd (M-Na)+ 237.0891; Found 237.0894. 
	
	
	
	
	
Phenyl(tetrahydro-2H-pyran-4-yl)methanone (13).37  General procedure B was em-
ployed using benzoyl chloride (42 mg, 0.3 mmol) and 5-(tetrahydro-2H-pyran-4-yl)-1-
aza-5-stannabicyclo[3.3.3]undecane (113 mg, 0.33 mmol).  A white solid (52 mg, 91%) 
was isolated by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, 
CDCl3): δ 7.96-7.93 (m, 2H), 4.09-4.03 (m, 2H), 3.61-3.45 (m, 3H), 1.96-1.76 (m, 4H) 
ppm. 13C NMR (75 MHz, CDCl3): 201.80, 135.80, 133.10, 128.80, 128.30, 67.30, 42.60, 
29.10 ppm. 
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1-(Benzo[b]thiophen-2-yl)-2-methylpropan-1-one (7).  General procedure C was 
employed using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(iso-
propyl)-1-aza-5-stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (42 
mg, 68%) was isolated by column chromatography (95:5 hexanes/ether). 1H NMR (300 
MHz, CDCl3): 7.97 (s, 1H), 7.91-7.86 (m, 2H), 7.49-7.38 (m, 2H), 3.60 – 3.46 (septet, J 
= 7 Hz, 1H), 1.31-1.29 (d, J = 6 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 199.2, 143.3, 
142.7, 139.43, 128.8, 127.5, 126.1, 125.2, 123.2, 37.3, 19.7 ppm. HRMS (ES+): Calcd 
(M-Na)+ 227.0507; Found 227.0527. 
	
	
	
	
1-(Benzofuran-2-yl)-2-methylpropan-1-one (8).35  General procedure C was employed 
using benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (38 mg, 68%) was 
isolated by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
7.71 (d, J = 9 Hz, 1H), 7.59 (dd, J = 1, 9 Hz, 1H), 7.52 (d, J = 1 Hz, 1H), 7.47 (dt, J = 3, 
5 Hz, 1H), 7.33 – 7.28 (m, 1H), 3.48 (heptet, J = 6.5 Hz, 1H), 1.28 (d, J = 6 Hz, 6H) ppm. 
13C NMR (75 MHz, CDCl3): 195.5, 155.6, 152.1, 128.1, 127.1, 123.8, 123.2, 112.8, 
112.5, 36.7, 18.8 ppm. 
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2-Methyl-1-(o-tolyl)butan-1-one (12). General procedure C was employed using o-
toluoyl chloride (46 mg, 0.3 mmol) and 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  A yellow liquid (47 mg, 89%) was 
isolated by column chromatography (99:1 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
7.54-7.22 (m, 4H), 3.25-3.14 (hex, J = 6.6 Hz, 1H), 2.44 (s, 3H), 1.89-1.75 (m, 1H), 1.53-
1.39 (m, 1H), 1.18 (d, J = 6 Hz, 3H), 0.95 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): 209.3, 139.3, 137.8, 130.9, 127.8, 125.7, 45.8, 26.4, 21.0, 16.4, 12.0 ppm. 
HRMS (ES+): Calcd (M-Na)+ 199.1099; Found 199.1113. 
	
	
	
	
(S)-2-Methyl-1-(o-tolyl)butan-1-one (18). General procedure C was employed using o-
toluoyl chloride (31 mg, 0.2 mmol) and 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (68 mg, 0.22 mmol, 99% ee).  A yellow liquid (27.5 mg, 
78%, 99% ee) was isolated by column chromatography. [a]20D (c 1.00, CHCl3) = +12.4º.   
% ee was determined using an OJ-RH (150x4.6) HPLC column with a 55%:45% metha-
nol:water eluent.  
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3-Methyl-1-phenylheptan-4-one (9).  General procedure B was employed using butyryl 
chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (129 mg, 0.33 mmol).  A colorless oil (48 mg, 79%) was 
isolated by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
7.31-7.15 (m, 5H), 2.60-2.37 (m, 5H), 2.00 (m, 1H), 1.69-1.53 (m, 3H), 1.13-1.10 (d, J = 
9 Hz, 3H), 0.91 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 214.7, 142.0, 
128.61, 128.58, 126.1, 45.9, 43.3, 34.7, 33.7, 17.3, 16.7, 14.0 ppm. HRMS (ES+): Calcd 
(M-Na)+ 227.1412; Found 227.1416. 
	
	
	
	
2,4-Dimethyl-6-phenylhexan-3-one (10).  General procedure B was employed using 
isobutyryl chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (129 mg, 0.33 mmol).  A yellow oil (55 mg, 89%) was 
isolated by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
7.31-7.15 (m, 5H), 2.76-2.67 (m, 2H), 2.59-2.53 (m, 2H), 2.06-1.94 (m, 1H), 1.68-1.55 
(m, 1H), 1.12-1.05 (m, 9H)  ppm. 13C NMR (75 MHz, CDCl3): 218.3, 142.1, 128.61, 
128.55, 126.1, 44.1, 39.8, 34.8, 33.8, 18.62, 18.59, 17.10 ppm. HRMS (ES+): Calcd (M-
H)+ 205.1592; Found 205.1594. 
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(S)-2,4-Dimethyl-6-phenylhexan-3-one (20).  General procedure B was employed using 
isobutyryl chloride (21.3 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 98% ee).  A yellow oil (35 mg, 85%, 
91% ee) was isolated by column chromatography (94:6 hexanes/ether). [a]20D (c 1.00, 
CHCl3) = +15.7º.  % ee was determined using an IA (250x4.6) HPLC column with a 
65%:35% [19:1 v/v methanol/acetonitrile]:water eluent.  
	
	
	
1-(3-Chlorophenyl)-2-methylpropan-1-one (5).34  General procedure B was employed 
using 3-chlorobenzoyl chloride (53 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (47 mg, 86%) was 
isolated by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
7.92 (t, J = 1.8 Hz, 1H), 7.83-7.80 (m, 1H), 7.53-7.52 (m, 1H), 7.41 (t, J = 8.0 Hz, 1H), 
3.49 (sept, J = 6.8 Hz, 1H), 1.21 (d, J = 6.8 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): 
203.3, 138.0, 135.0, 132.8, 130.0, 128.5, 126.4, 35.7, 19.1 ppm. 
 
	
	
1-(4-Chlorophenyl)-2-methylpropan-1-one (4).38  General procedure B was employed 
using 4-chlorobenzoyl chloride (53 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (44 mg, 81%) was 
isolated by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 
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7.89 (d, J = 9 Hz, 2H), 7.43 (d, J = 9 Hz, 2H), 3.50 (septet, J = 7 Hz, 1H), 1.21 (d, J = 9 
Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): 203.2, 139.2, 134.5, 129.7, 128.9, 35.4, 19.1 
ppm. 
 
	
	
1-(Benzo[d][1,3]dioxol-5-yl)-2-methylpropan-1-one (6).39  General procedure B was 
employed using piperonyloyl chloride (55 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (55.3 mg, 96%) 
was isolated by column chromatography (90:10 pentane/MTBE). 1H NMR (300 MHz, 
CDCl3): δ 7.49 (dd, J = 8.1, 1.7 Hz, 1H), 7.37 (d, J = 1.7 Hz, 1H), 6.78 (d, J = 8.3 Hz, 
1H), 5.97 (s, 2H), 3.39 (sept, J = 6.8 Hz, 1H), 1.12 (d, J = 6.9 Hz, 6H); ppm. 13C NMR 
(75 MHz, CDCl3): δ 202.6, 151.5, 148.2, 131.0, 124.3, 108.3, 107.9, 101.8, 35.1, 19.4 
ppm. 
	
	
	
Benzo[b]thiophen-2-yl(tetrahydro-2H-pyran-4-yl)methanone (14).  General proce-
dure C was employed using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) 
and 5-(tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (113 mg, 0.33 
mmol). A pale yellow solid (51 mg, 69%) was isolated by column chromatography (97:3 
hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.99 (s, 1H), 7.91-7.87 (m, 2H), 7.51-7.39 
(m, 2H), 4.13-4.07 (m, 2H), 3.63-3.44 (m, 3H), 2.06-1.84 (m, 4H) ppm. 13C NMR (75 
O
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MHz, CDCl3): 196.2, 142.6, 142.5, 139.1, 128.80, 127.5, 125.9, 125.1, 123.0, 67.2, 44.2, 
29.3 ppm. HRMS (ES+): Calcd (M-Na)+ 269.0612; Found 269.0615. 
	
																																												
	
	
1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one (15b).40  General procedure D was 
employed using 4-methoxybenzoyl chloride (51 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  A colorless liquid (24 mg, 42%) 
was isolated by column chromatography (90:10 hexanes/ether). 1H NMR (500 MHz, 
CDCl3): δ 7.85 (d, J = 9.0 Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 3.85 (s, 3H) 1.37 (s, 9H) 
ppm. 13C NMR (75 MHz, CDCl3): 206.3, 162.0, 131.0, 130.1, 113.2, 55.4,  43.9, 28.4 
ppm. 
	
	
	
	
2-Methyl-1-(naphthalen-2-yl)butan-1-one (11).36  General procedure B was employed 
using 2-naphthoyl chloride (57 mg, 0.3 mmol) and 5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  An orange liquid (48 mg, 75%) was 
isolated by column chromatography (93:7 hexanes/EtOAc). 1H NMR (300 MHz, CDCl3): 
δ 8.47 (s, 1H), 8.06-7.87 (m, 4H), 7.57 (quintet. d, J = 3, 7.5 Hz, 2H), 3.58 (sextet, J = 7.2 
Hz, 1H), 1.97-1.83 (m, 1H), 1.63–1.50 (m, 1H), 1.26 (d, J = 6 Hz, 3H), 0.96 (t, J = 6 Hz, 
tBu
O
MeO
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3H) ppm. 13C NMR (75 MHz, CDCl3): δ 204.7, 135.7, 134.4, 132.8, 129.8, 129.7, 128.7, 
128.5, 128.0, 126.9, 124.5, 42.4, 27.1, 17.2, 12.1 ppm. 
	
	
	
2,2-Dimethyl-1-(naphthalen-2-yl)propan-1-one (15a).37 General procedure D was 
employed using 2-naphthoyl chloride (57 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  A pale yellow solid (44 mg, 69%) 
was isolated by column chromatography (95:5 hexanes/EtOAc). 1H NMR (300 MHz, 
CDCl3): δ 8.24 (s, 1H), 7.93-7.77 (m, 4H), 7.59-7.51 (m, 2H), 1.43 (s, 9H) ppm. 13C 
NMR (75 MHz, CDCl3): 209.2, 136.0, 134.5, 132.6, 129.3, 128.7, 128.0, 127.9, 126.8, 
125.1, 124.22, 44.6, 28.4 ppm. 
	
	
	
1-(Benzofuran-2-yl)-2-phenylbutan-1-one (17).  General procedure C was employed 
using benzofuran-2-carbonyl chloride (36 mg, 0.2 mmol) and (S)-5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (68 mg, 0.22mmol, 91% ee).  A colorless oil (27 mg, 67%, 
88% ee) was isolated by column chromatography (99:1 hexanes/ether). [a]20D (c 1.00, 
CHCl3) = +3.2º. % ee was determined using an IA (250x4.6) HPLC column with a 
60%:40% methanol:water eluent. 1H NMR (300 MHz, CDCl3): δ 7.71 (d, J = 7.5 Hz, 
1H), 7.60-7.44 (m, 3H), 7.31 (dt, J = 3, 7.5 Hz, 1H), 3.32 (sextet, J = 6.6 Hz, 1H), 1.94-
1.82 (m, 1H), 1.63-1.49 (m, 1H), 1.25 (d, J = 6 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H) ppm. 13C 
tBu
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NMR (75 MHz, CDCl3): 195.50, 155.63, 152.11, 128.07, 127.10, 123.83, 123.20, 112.80, 
112.45, 36.70, 18.79 ppm. HRMS (ES+): Calcd (M-H)+ 203.1072; Found 203.1072.  
	
	
	
	
1,4-Diphenyl-2-methyl-1-butanone (19).41  General procedure B (acyl chloride) was 
employed using benzoyl chloride (17 mg, 0.1 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-
aza-5-stannabicyclo[3.3.3]undecane (43 mg, 0.11mmol, 99% ee).  A colorless oil (18.5 
mg, 78%, 99% ee) was isolated by column chromatography (95:5 hexanes/ether). [a]20D 
(c 1.00, CHCl3) = +27.8º.  % ee was determined using an IA (250x4.6) HPLC column 
with a 80%:20% [19:1 v/v methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 
7.8) eluent. 1H NMR (300 MHz, CDCl3): δ 7.88-7.85 (m, 2H), 7.58-7.52 (m, 1H), 7.46-
7.41 (m, 2H), 7.31-7.16 (m, 5H), 3.47 (sextet, J = 6.6 Hz, 1H), 2.65 (t, J = 7.5 Hz, 2H), 
2.24-2.12 (m, 1H), 1.81-1.70 (m, 1H), 1.24 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): 204.3, 142.0, 136.8, 133.1, 128.8, 128.7, 128.6, 128.5, 126.1, 39.9,  35.4, 33.7, 
17.5 ppm.  
 
General procedure E (thioester) was employed using Pd(PPh3)4 (2 mol %), CuCl (2 
equiv), S-phenyl benzothioate (42.8 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-
5-stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 91% ee).  A colorless oil (38.5 mg, 
81%, 90% ee) was isolated by column chromatography (95:5 hexanes/ether). % ee was 
determined using an IA (250x4.6) HPLC column with a 75%:25% methanol:sodium 
phosphate buffer (25mM, pH 7.8) eluent.   
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1-(Isoxazol-5-yl)-2-methyl-4-phenylbutan-1-one (21).  General procedure C was 
employed using isoxazole-5-carbonyl chloride (26.3 mg, 0.2 mmol) and 5-(4-
phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 95% ee).  
A colorless oil (34.4 mg, 75%, 99% ee) was isolated by column chromatography (75:25 
hexanes/ether). [a]20D (c 1.00, CHCl3) = +18.0º.  % ee was determined using an OJ-RH 
(150x4.6) HPLC column with a 70%:30% [19:1 v/v methanol/acetonitrile]:water eluent. 
1H NMR (300 MHz, CDCl3): δ 8.34 (d, J = 3.0 Hz, 1H), 7.27-7.14 (m, 1H), 6.85 (d, J = 
3Hz, 5H), 3.38 (sextet, J = 7.2 Hz, 1H), 2.65 (t, J = 6 Hz, 2H), 2.25-2.12 (m, 1H), 1.88-
1.73 (m, 1H), 1.28 (d, J = 6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 193.0, 166.0, 
150.9, 141.5, 128.7, 128.6, 126.3, 107.4, 42.9, 34.4, 33.6, 16.5 ppm. HRMS (ES+): Calcd 
(M-H)+ 230.1181; Found 230.1155.   
	
	
	
	
Ethyl 3-methyl-4-(naphthalen-2-yl)-4-oxobutanoate (24).  General procedure B was 
employed using 2-naphthoyl chloride (57 mg, 0.3 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (49 
mg, 71%) was isolated by column chromatography (90:10 hexanes/ether). For the enanti-
oenriched carbastannatrane variant, general procedure B was employed using 2-
naphthoyl chloride (0.05 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-
O
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yl)butanoate (0.055 mmol, 97% ee).  The product yield (75%, 96% ee) was determined 
by calibrated gas chromatography. % ee was determined using an OJ-RH (150x4.6) 
HPLC column with a 70%:30% [19:1 v/v methanol/acetonitrile]:sodium phosphate buffer 
(25mM, pH 7.8) eluent.  1H NMR (300 MHz, CDCl3): δ 8.53 (br s, 1H), 8.06-7.87 (m, 
4H), 7.58 (dquintet, J = 1.8, 7.5 Hz, 2H), 4.16-4.07 (m, 3H), 3.06-2.97 (dd, J = 9, 18 Hz, 
1H), 2.55-2.47 (dd, J = 6, 18 Hz, 1H), 1.29 (d, J = 6.0 Hz, 3H), 1.21 (t, J = 6.0 Hz, 3H) 
ppm. 13C NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8, 130.2, 129.8, 128.8, 
128.7, 128.0, 127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. HRMS (ES+): Calcd (M-H)+ 
271.1334; Found 271.1335. 
	
	
	
 
Ethyl 4-(furan-2-yl)-3-methyl-4-oxobutanoate (22).  General procedure C was em-
ployed using 2-furoyl chloride (39 mg, 0.3 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (50 
mg, 79%) was isolated by column chromatography (80:20 hexanes/EtOAc). For the 
enantioenriched carbastannatrane variant, general procedure C was employed using 2-
furoyl chloride (0.05 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-
yl)butanoate (0.055 mmol, 97% ee). The product yield (78%, 96% ee) was determined by 
calibrated gas chromatography. % ee was determined using an IA (250x4.6) HPLC 
column with a 50%:50% [19:1 v/v methanol/acetonitrile]:sodium phosphate buffer 
(25mM, pH 7.8) eluent.   1H NMR (300 MHz, CDCl3): δ 7.60 (br s, 1H), 7.24 (d, J = 3 
Hz, 1H), 6.55-6.53 (dd, J = 3, 3 Hz, 1H), 4.09(q, J = 6.0 Hz, 2H), 3.72 (sextet, J = 6.6 Hz, 
O
O
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1H), 2.95-2.87 (dd, J = 9, 15 Hz, 1H), 2.46-2.38 (dd, J = 6, 18 Hz, 1H), 1.25-1.17 (m, 
6H) ppm. 13C NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8, 130.2, 129.8, 
128.8, 128.7, 128.0, 127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. 13C NMR (125 MHz, 
CDCl3): 191.8, 172.3, 152.2, 146.7, 117.8, 112.5, 60.8, 38.1, 37.3, 17.8, 14.3 ppm. 
HRMS (ES+): Calcd (M-H)+ 211.0970; Found 211.0960.   
	
	
 
 
Ethyl 4-(4-chlorophenyl)-3-methyl-4-oxobutanoate (23).42  General procedure C was 
employed using 4-chlorobenzoyl chloride (53 mg, 0.3 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (71 
mg, 93%) was isolated by column chromatography (90:10 hexanes/ether). For the enanti-
oenriched carbastannatrane variant, general procedure C was employed using 4-
chlorobenzoyl chloride (0.05 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-
yl)butanoate (0.055 mmol, 99% ee). The product yield (93%, 99% ee) was determined by 
calibrated gas chromatography. % ee was determined using an IA (250x4.6) HPLC 
column with a 70%:30% methanol:sodium phosphate buffer (25mM, pH 7.8) eluent. 1H 
NMR (300 MHz, CDCl3): δ 7.94 (d, J = 9.0 Hz, 2H), 7.46 (d, J = 9.0 Hz, 2H), 4.12 (q, J 
= 7.0 Hz, 2H), 3.89 (sextet, J = 7.2 Hz, 1H), 3.00-2.91 (dd, J = 9, 18 Hz, 1H), 2.49-2.41 
(dd, J = 6, 18 Hz, 1H), 1.23-1.18 (m, 6H) ppm. 13C NMR (75 MHz, CDCl3): 201.9, 
172.4, 139.7, 134.5, 130.1, 129.2, 60.8, 37.7, 37.4, 18.0, 14.3 ppm.   
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1-(Benzofuran-2-yl)-2-phenylbutan-1-one (25).  General procedure C was employed 
using benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(1-phenylpropyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol). A yellow oil (63 mg, 80%) was 
isolated by column chromatography (95:5 hexanes/ether). For the enantioenriched carbas-
tannatrane variant, general procedure C was employed using benzofuran-2-carbonyl 
chloride (0.05 mmol) and 5-(1-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(0.055 mmol, 99% ee). The product yield (78%, 97% ee) was determined by calibrated 
gas chromatography.  % ee was determined using an OJ-RH (150x4.6) HPLC column 
with a 80%:20% [19:1 v/v methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 
7.8) eluent.  1H NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 10H), 4.40 (t, J = 7.5 Hz, 1H), 
2.30-2.21 (m, 1H), 1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): 191.3, 155.8, 152.7, 139.2, 129.02, 128.6, 128.4, 127.4, 127.3, 124.0, 123.5, 
113.7, 112.7, 56.3, 26.5, 12.5 ppm. HRMS (ES+): Calcd (M-Na)+ 287.1048; Found 
287.1067.   
	
	
	
	
1-(Benzo[b]thiophen-2-yl)-2-phenylbutan-1-one (26).  General procedure C was 
employed using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(1-
O
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phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol).  A pale 
yellow solid (51 mg, 69%) was isolated by column chromatography (97:3 hexanes/ether).  
For the enantioenriched carbastannatrane variant, general procedure C was employed 
using benzo[b]thiophene-2-carbonyl chloride (0.05 mmol) and 5-(1-phenylpropyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (0.055 mmol, 99% ee). The product yield (71%, 99% ee) 
was determined by calibrated gas chromatography. % ee was determined using an OJ-RH 
(150x4.6) HPLC column with a 80%:20% [19:1 v/v methanol/acetonitrile] : sodium 
phosphate buffer (25mM, pH 7.8) eluent.  1H NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 
10H), 4.40 (t, J = 7.5 Hz, 1H), 2.30-2.21 (m, 1H), 1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 
3H) ppm. 13C NMR (75 MHz, CDCl3): 191.3, 155.8, 152.7, 139.2, 129.0, 128.6, 128.4, 
127.4, 127.3, 124.0, 123.5, 113.7, 112.7, 56.3, 26.5, 12.5 ppm. HRMS (ES+): Calcd (M-
H)+ 281.1000; Found 281.0984.  
	
	
	
	
(2S,4R)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (syn-29).   General 
procedure E was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 
equiv), S-phenyl (S)-2-(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, 
>99% ee) and (R)-5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 
mmol, 99% ee).  A white solid (32.5 mg, 60%, 49:1 dr) was isolated by column chroma-
tography (97:3 hexanes/ether). [a]20D (c 1.00, CHCl3) = +183.9º.
 1H NMR (300 MHz, 
CDCl3): δ 7.71-7.62 (m, 3H), 7.32-7.29 (dd, J = 3, 9 Hz ,1H), 7.17-7.11 (m, 2H), 4.03 (q, 
J = 6 Hz, 1H), 3.91 (s, 3H), 2.58 (app. sextet, J = 8.4 Hz, 1H), 1.61-1.44 (m, 4H), 1.22 
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(app. heptet, J = 6 Hz, 1H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.79 (m, 1H), 0.55 (t, J = 7.5 Hz, 
3H) ppm. 13C NMR (75 MHz, CDCl3): 214.49, 157.84, 135.64, 133.84, 129.38, 129.26, 
127.51, 126.97, 126.85, 119.25, 106.81, 55.51, 51.56, 46.57, 25.63, 18.27, 17.48, 11.80 
ppm. HRMS (ES+): Calcd (M-Na)+ 293.1517; Found 293.1515.   
	
	
	
	
(2S,4S)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (anti-29).   General 
procedure E was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 
equiv), S-phenyl (S)-2-(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, 
>99% ee) and (S)-5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 
mmol, 91% ee).  A pale yellow solid (35 mg, 65%, 22:1 dr) was isolated by column 
chromatography (97:3 hexanes/ether. [a]20D (c 1.00, CHCl3) = +160.9º. 
1H NMR (300 
MHz, CDCl3): δ 7.71-7.61 (m, 3H), 7.31-7.28 (dd, J = 3, 9 Hz ,1H), 7.17-7.11 (m, 2H), 
3.98 (q, J = 5.25 Hz, 1H), 3.92 (s, 3H), 2,61 (sextet, J = 6.6 Hz, 1H), 1.65 (heptet, J = 7 
Hz, 1H), 1.47-1.32 (m, 4H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.84 (m, 6H) ppm. 13C NMR 
(75 MHz, CDCl3): 215.03, 157.87, 135.91, 133.83, 129.38, 129.29, 127.59, 126.92, 
126.82, 119.30, 106.81, 55.54, 52.65, 46.29, 27.13, 18.11, 16.30, 11.89 ppm. HRMS 
(ES+): Calcd (M-Na)+ 293.1517; Found 293.1515.   
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HPLC & NMR Data 
	
	
	
	
 
CONDITIONS 
Column IA-3mm 150x4.6 
Mobile Phase 100 : 0.1 Hexane : IPA 
Flow 0.6 mL/min 
Detector 220nm 
Temp 25°C 
	
	
Sn
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>99% ee
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CONDITIONS 
Column Chiralcel OJ-H 250x4.6 
Mobile Phase 95 : 5  Methanol : Water 
Flow 1.0 mL/min 
Detector 215nm 
Temp 25°C 
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CONDITIONS 
Column Chiralcel OJ-H 250x4.6 
Mobile Phase 95 : 5  Methanol : Water 
Flow 1.0 mL/min 
Detector 290nm 
Temp 25°C 
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CONDITIONS	
Column IA 250x4.6 
m-Phase 57% : 43% Methanol : Water 
Flow 1.3 mL/min 
Detector 210 nm 
Temp 25°C 
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CONDITIONS 
Column IA 250x4.6 
Mobile Phase 75% : 25% Methanol : Sodium phosphate buffer (25mM, pH 7.8) 
Flow 1 mL/min 
Detector 210 nm 
Temp 25°C 
																				
O
CH3
90% ee (99% es)
(using thioester)
O
CH3
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CONDITIONS 
Column IA 250x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 1 mL/min 
Detector 205 nm 
Temp 25°C 
	
O
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O
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99% ee (100% es)
(using acyl chloride)
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CONDITIONS 
Column OJ-RH 150x4.6 
Mobile Phase 70% : 30% [19:1 v/v Methanol/Acetonitrile] : Water  
Flow 1.0 mL/min 
Detector 220 nm 
Temp 25°C 
	
	
	
O
CH3
O
N
94% ee (99% es)
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CONDITIONS 
Column OJ-RH 150x4.6 
Mobile Phase 70% : 30%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 0.8 mL/min 
Detector 205 nm 
Temp 25°C 
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O
CH3
OEt
O
 155 
	
	
CONDITIONS 
Column OJ-RH 150x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 1 mL/min 
Detector 215, 254 nm 
Temp 25°C 
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CONDITIONS 
Column OJ-RH 150x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 0.4 mL/min 
Detector 215 nm 
Temp 25°C 
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CONDITIONS 
Column  IA 250x4.6 
Mobile Phase 70% : 30% Methanol : Sodium phosphate buffer (25mM, pH 7.8)  
Flow 1.0 mL/min 
Detector 210 nm 
Temp 25°C 
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CONDITIONS 
Column IA 250x4.6 
Mobile Phase 65% : 35% [19:1 v/v Methanol/Acetonitrile] : Water  
Flow 1.0 mL/min 
Detector 220 nm 
Temp 25°C 
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CONDITIONS 
Column IA 250x4.6 
Mobile Phase 50% : 50%   [19:1 v/v Methanol/Acetonitrile] : Water 
Flow 0.6 mL/min 
Detector 210 nm 
Temp 25°C 
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CONDITIONS 
Column OJ-RH 150x4.6 
Mobile Phase 55% : 45%  Methanol : Water 
Flow 1.2 mL/min 
Detector 220 nm 
Temp 25°C 
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CONDITIONS 
Column IA 250x4.6 
Mobile Phase  60% : 40% Methanol : Water 
Flow 1.2 mL/min 
Detector 215 nm 
Temp 25°C 
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CONDITIONS 
Column IA 250x4.6 
m-Phase  45% : 55%  Acetonitrile : Sodium phosphate buffer (25mM, pH 
7.8) 
Flow 1.2 mL/min 
Detector 210 nm 
Temp 25°C 
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VCD analysis of absolute stereochemistry of product from acylation of (R)-19 
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Table 1. Numerical comparison describing the similarity in the range of 1300-1800 cm-1 between 
the calculated IR and VCD spectra for the (R) enantiomer at the B3LYP/6-31G(d) level and the 
observed IR and VCD spectra for PhenAcyl. 
 
 
 
Cal. 
(1300-1800 cm-1) 
Numerical 
comparison 
Observed 
PhenAcyl 
 scaling factor 0.96 
 IR similarity (%) 65.9 
(R) a∑ (%) 51.1406 
 b∆ (%) 43.915 
 Confidence Level (%) 90 
 
a∑: single VCD similarity, gives the similarity between the calculated and observed VCD spectra.  
b∆: enatiomeric similarity index, gives the difference between the values of ∑ for both enantiomers 
of a given diastereoisomer. 
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GENERAL INFORMATION  
Customer 
Sales Order Number 
CUNY 
2015.147B 
Sample code (Our ref.) PhenAcyl 
Sample description (Your ref.) PhenAcul 
VCD-spectrometer ChiralIR w/ DualPEM 
Report prepared by Bo Wang 
Report validated and signed by Rina K Dukor 
Date Nov. 12, 2015 
RESULTS  
Absolute Configuration of PhenAcyl is (R). Confidence Level: 90 % 
MEASUREMENT PARAMETERS  
Concentration 5.7 mg/0.15mL 
Solvent CDCl3 
Resolution 4 cm-1 
PEM setting 1400 cm–1 
Number of scans/Measurement time 6 hours 
Sample cell BaF2 
Path length 100 µm 
CALCULATION DETAILS  
Gaussian version Gaussian 09 
Total low-energy conformer used for Boltzmann sum 13 
Methodology and basis set for DFT calculations B3LYP/6-31G(d) 
Enantiomer used for calculation  (R) 
Total calculated conformers 
 
13 
 
Number of low-energy conformations shown in report  1 
 
COMMENTS 
 
 
Ph Cl
O
+ SnN
CH3
Pd(PPh3)4 (2 mol %)
CuCl (2 equiv)
CH3CN, 60 ºC
(R)-19 (99% ee)
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99% ee
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3
 
IR (lower frame) and VCD (upper frame) spectra of PhenAcyl in CDCl3 (6.4mg/0.15mL); 0.1mm 
path-length cell with BaF2 windows; 11 h collection for samples and solvent; instrument optimized at 
1400 cm-1.  Solvent-subtracted IR and VCD spectra are shown.  Uppermost trace is the VCD noise 
spectra. 
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IR (lower frame) and VCD (upper frame) spectra observed for PhenAcyl (right axes) compared with 
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